US20030100945A1 - Implantable intraluminal device and method of using same in treating aneurysms - Google Patents
Implantable intraluminal device and method of using same in treating aneurysms Download PDFInfo
- Publication number
- US20030100945A1 US20030100945A1 US10/216,356 US21635602A US2003100945A1 US 20030100945 A1 US20030100945 A1 US 20030100945A1 US 21635602 A US21635602 A US 21635602A US 2003100945 A1 US2003100945 A1 US 2003100945A1
- Authority
- US
- United States
- Prior art keywords
- aneurysm
- tube
- filaments
- diameter
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/821—Ostial stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/823—Stents, different from stent-grafts, adapted to cover an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/909—Method or apparatus for assembling prosthetic
Definitions
- the present invention relates to intraluminal devices implantable in a blood vessel for the treatment of aneurysms especially brain aneurysms.
- the invention also relates to methods of treating aneurysms using such intraluminal devices.
- Intracranial aneurysms are the main cause of nontraumatic subarachnoid hemorrhage and are responsible for about 25% of all deaths relating to cerebrovascular events. Autopsy studies show that the overall frequency of intracranial aneurysms in the general population is approximately 5 percent and suggest that 10 to 15 million persons in the United States have or will have intracranial aneurysms [1]. In approximately 15,000 cases (6 cases per 100,000 persons per year), intracranial aneurysms rupture every year in North America [2].
- SAH subarachnoid aneurysmal hemorrhage
- the extravascular approach involves surgery or microsurgery of the aneurysm.
- One surgical procedure is to apply a metallic clip or a suture-ligation across the artery feeding the aneurysm (neck), thereby allowing the aneurysm to clot off and hopefully shrink.
- Another surgical procedure is to “surgically reconstruct” the aneurysmal portion of the artery, by surgically cut out the aneurysm and repairing the vessel by using a natural or synthetic vessel graft. Both of these surgical procedures typically require general anesthesia, craniotomy, brain retraction, and dissection of the arachnoid around the neck of the aneurysm.
- Another endovascular technique for treating aneurysms involves inserting a detachable balloon into the sac of the aneurysm using a microcatheter.
- the detachable balloon is then inflated using embolic material, such as a liquid polymer material or microcoils.
- embolic material such as a liquid polymer material or microcoils.
- the balloon is then detached from the microcatheter and left within the sac of the aneurysm in an attempt to fill the sac and to form a thrombotic mass inside the aneurysm.
- detachable balloons when inflated, typically do not conform to the interior configuration of the aneurysm sac. Instead, the aneurysm sac is forced to conform to the exterior surface of the detachable balloon. Thus, there is an increased risk that the detachable balloon will rupture the sac of the aneurysm.
- Stent technology has been applied to the intracranial vasculature.
- the use of this technology has been limited until recently by the lack of available stents and stent delivery systems capable of safe and effective navigation through the intercranial vessels.
- the use of such stents is particularly difficult with respect to aneurysms in head blood vessels because of the number of perforating vessels in such blood vessels, and thereby the increased danger that one or more perforating vessels may be in the vicinity of such an aneurysm.
- bifurcations of a blood vessel splitting into one or more branch vessels which may also be in the vicinity of an aneurysm.
- Stents having portions of different permeabilities are disclosed, for example, in McCrory U.S. Pat. No. 5,951,599, Brown et al U.S. Pat. No. 6,093,199, Wallsten U.S. Pat. No. 4,954,126, and Dubrul U.S. Pat. No. 6,258,115.
- the McCrory patent discloses a braided stent having a first portion with a relatively high porosity index so as to be highly permeable to blood flow, and a second portion of lower porosity index so as to be less permeable to blood flow.
- the portion of low permeability is located to overlie the neck of the aneurysm, and the portion of high permeability is spaced from the neck of the aneurysm.
- a braided stent construction with different porosities is also disclosed in the Dubrul patent.
- Brown et al discloses an intraluminal device or stent comprising a diverter, in the form of a low-permeability foam pad, to overlie the neck of the aneurysm, straddled on its opposite sides by a pair of high-permeability coil elements for anchoring the device in the blood vessel.
- Wallsten U.S. Pat. No. 4,954,126 discloses a braided tube intraluminal device for use in various applications, one of which applications is to apply a graft to treat an aneurysm (FIG. 9).
- the complete braided tube would have high permeability with respect to blood flow therethrough since its function is to mount the grafts, but the graft would have low-permeability to decrease the possibility of rupture of the aneurysm.
- Delivery devices for stents for use in the intracranial vasculature are well known at the art. Typical devices are disclosed, for example, in the following U.S. Pat. Nos. 5,496,275; 5,676,659; and 6,254,628.
- the blood vessels in the brain are frequently as small as several millimeters, requiring that the catheters have an outside diameter as small as 2-8 French (0.66 mm to 2.64 mm).
- Another object of the invention is to provide an implantable intraluminal device for treating aneurysms in the intracranial vasculature that is sufficiently flexible and pliable so that it can be delivered easily to an intracranial site, deployed accurately, and then left in position to accomplish its purpose.
- a further object of the invention is to provide a method of treating aneurysms by using intraluminal devices having the above features.
- an intraluminal device implantable in a blood vessel having an aneurysm therein in the vicinity of a perforating vessel, and/or of a bifurcation leading to a branch vessel, the device comprising: a mesh-like tube of bio-compatible material having an expanded condition in which the tube diameter is slightly larger than the diameter of the blood vessel in which it is to be implanted, and the tube length is sufficient to straddle the aneurysm and to be anchored to the blood vessel on the opposite sides of the aneurysm; the mesh-like tube also having a contracted condition wherein it is sufficiently flexible so as to be easily manipulatable through the blood vessel to straddle the aneurysm; the mesh-like tube, in its expanded condition, having a porosity index of 55%-80% such as to reduce the flow of blood through a wall of the mesh-like tube to the aneurysm sufficiently to decrease the possibility of rupture of the aneurysm but not to unduly reduce the blood
- the windows in the mesh-like tube produce a porosity index of 50%-85%, preferably 60%-75%.
- “Sm” is the actual surface covered by the mesh-like tube
- “St” is the total surface area of the mesh-like tube.
- the porosity index of the existing typical stents is well above 80%. In the tube devices of the present invention, however, the porosity index is not more than 85%, preferably 55-80%, more preferably 60-75%.
- the mesh-like tube includes windows having an inscribed diameter of 30-480 ⁇ m, preferably 50-320 ⁇ m, in the expanded condition of the mesh-like tube.
- the mesh-like tube includes a plurality of filaments of bio-compatible material extending helically in an interlaced manner in opposite directions so as to form a braided tube. It is contemplated, however, that other mesh-like structures could be used, such as woven or knitted tubes.
- a maximum porosity index is attained when the braiding angle, in the expanded condition of the braided tube, is 90°.
- decreasing the braiding angle below 90° increases the radial force applied by the braided tube against the inner surface of the blood vessel and decreases the P.E.
- the desirable low P.E. can be achieved by increasing or decreasing the braiding angle, as described below with respect to specific examples.
- the braided tube has a braiding angle in the range of 20%-150% in the expanded condition of the braided tube.
- the filaments are of circular cross-section and have a diameter of 10-60 ⁇ m, preferably 20-40 ⁇ m.
- the filaments could also be of non-circular cross-section, such as of square or rectangular cross-section, in which case it is preferred that they have a circumference of 40-180 ⁇ m. It is also possible to use combination of several filament diameters and filament materials in one device to achieve structural stability and/or desired radio-opacity characteristic.
- the braid is formed of 24-144 filaments, more preferably 62-120 filaments.
- the filaments may be of a suitable bio-compatible material, metal or plastic, and may include a drug or other biological coating or cladding.
- a method of treating an aneurysm in a blood vessel which may be proximate to one or more perforating vessels and/or to a bifurcation leading to a branch vessel, by using intraluminal devices having the above combination of features.
- intraluminal devices constructed in accordance with the foregoing features show great promise in the treatment of aneurysms in general, and brain aneurysms in particular, since they are relatively easily manipulatable through the blood vessel to the implantation site, and when deployed in their expanded condition in the implantation site, they reduce the flow of blood to the aneurysm sufficiently to decrease the possibility of rupture thereof, while maintaining patency in any perforating or branch vessels in the vicinity of the aneurysm.
- FIGS. 1 a and 1 b are side and end view, respectively, illustrating one form of intraluminal device constructed in accordance with the present invention, the device being shown in its normal, expanded condition;
- FIGS. 2 a and 2 b are corresponding views but illustrating the device in its contracted, stressed condition
- FIG. 3 more particularly illustrates the braid pattern of FIGS. 1 a , 1 b and 2 a , 2 b in the expanded condition of the braided tube;
- FIG. 4 illustrates another braid pattern, wherein one filament extending in one helical direction is interwoven over and under two filaments extending in the opposite helical direction;
- FIG. 5 illustrates a further braid pattern in which two (or more) filaments extending helically in one direction are interwoven over and under two (or more) filaments extending in the opposite direction;
- FIG. 6 schematically shows the relationship between the bending rigidity of the braided tube with respect to the diameter of the filaments producing the braided tube;
- FIG. 7 schematically illustrates an intraluminal device implanted in a blood vessel having a plurality of perforating vessels in the vicinity of an aneurysm
- FIGS. 8, 9, and 10 illustrate various manners in which an intraluminal device constructed in accordance with the present invention may be implanted in a blood vessel having an aneurysm at or proximate to a bifurcation leading to one or more branch vessels.
- FIGS. 1 a and 1 b illustrate an intraluminal device, therein generally designated 2 , constructed in accordance with the present invention in its normal or expanded condition which it assumes in a blood vessel after deployment therein; whereas FIGS. 2 a and 2 b illustrate the intraluminal device 2 of FIGS. 1 a and 1 b in the contracted or stressed condition of the device which assumes to facilitate its manipulation through the blood vessel to the deployment site.
- the intraluminal device includes a plurality of filaments of elastic and non-elastic bio-compatible material, metal or plastic, extending helically in an interlaced manner to define a braided tube.
- filaments of elastic and non-elastic bio-compatible material metal or plastic
- FIG. 1 a show a first group of filaments 3 extending helically in one direction, and a second group of filaments 4 extending helically in the opposite direction, with the two groups of filaments being interwoven such that a filament 3 overlies a filament 4 at some points as shown at 5 , and underlies a filament 4 at other points as shown at 6 .
- Filaments 3 and 4 thus define a braided tube having a plurality of windows 7 .
- the inscribed diameter and the length of each window are shown at W d and W L , respectively, in the normal, expanded condition of the braided tube. These characteristics depend on, among other factors, the number of filaments and the braiding angle “ ⁇ ” at the cross-over points of the two groups of filaments 3 , 4 .
- FIG. 3 more particularly illustrates the above-described braid pattern in the expanded condition of the braided tube.
- each filament 3 a extending helically in one direction and is interwoven with one filament 4 a extending helically in the opposite direction.
- Such a braid pattern is sometimes called a “one over one” pattern.
- FIG. 4 illustrates a “one over two” pattern, in which each filament 3 b extending helically in one direction is interwoven with two filaments 4 b extending helically in the opposite direction.
- FIG. 5 illustrates a further braid pattern that may be used, in which two (or more) filaments 3 c extending helically in one direction are interwoven with two (or more) filaments 4 c extending helically in the opposite direction.
- the braid pattern illustrated in FIG. 3 is of highest flexibility, whereas that illustrated in FIG. 5 is of lower flexibility but of higher strength.
- Such braided-tube intraluminal devices are well-known, for example as described in Wallsten et al, U.S. Pat. No. 5,061,275 and Wallsten U.S. Pat. No. 4,954,126, the contents of which are incorporated herein by reference. They are generally used as stents for providing support to a wall of a blood vessel, for implanting a graft, e.g., to treat an aneurysm (FIG. 9 of the latter patent), or for other purposes.
- the braided tube is normally formed in an expanded condition (FIGS. 1 a , 1 b ) having a diameter slightly larger than the diameter of the blood vessel so that when the device is deployed it becomes firmly embedded in the wall of blood vessel.
- the braided tube is capable of being stressed into a contracted condition, as shown in FIGS. 2 a and 2 b , wherein the diameter of the braided tube is decreased, and its length increased, to permit manipulation of the braided tube through the blood vessel to the site of implantation.
- the filaments forming the braided tube are generally of a diameter exceeding 50 ⁇ m and define windows producing a porosity index exceeding 80%.
- Such constructions do not have the combination of flexibility to enable them to be easily manipulated through the tortuous blood vessels of the intracranial vascular system for preventing intracranial aneurysm ruptures, and blood permeability to enable them to be used for treating aneurysm at or proximate to perforating vessels, or a bifurcation leading to a branch vessel.
- the filaments making up the braided tube are of a sufficiently small size in cross-section and define windows of a size such that the braided tube, when in its contracted condition, is sufficiently flexible so as to be easily manipulatable through the blood vessel to straddle the aneurysm; and when in its expanded condition straddling the aneurysm, reduces the flow of blood through the braided tube to the aneurysm sufficiently to decrease the possibility of rupture of the aneurysm.
- the windows defined by the filaments of the braided tube are such as to reduce the flow of blood therethrough to the aneurysm to decrease the possibility of rupturing it, but not to unduly reduce the blood flow to the perforating or branch vessels to the degree likely to cause damage to tissues supplied with blood by such vessels.
- experimental evidence indicates that patency can be maintained, and ischemia and infarction can be prevented, if less than 50% of the ostial diameter of the branch vessel is occluded.
- FIG. 6 schematically illustrates how the bending rigidity or flexibility of a braided tube varies with the diameter of the filaments.
- Region A in FIG. 6 illustrates typical diameters in conventional stents used for supporting blood vessels, which region usually starts above 50 ⁇ m and extends to several hundred ⁇ m.
- Region B in FIG. 6 illustrates the region of filament diameters for use in constructing braided tubes in accordance with the present invention.
- the filament diameters in this region would be significantly smaller than in region A, preferably being 10-60 ⁇ m, more preferably 20-40 ⁇ m.
- the foregoing dimensions apply to the diameters of filaments of circular cross-section.
- the filaments are of non-circular cross-section, such as of rectangular or square cross-section, the filaments would preferably have a circumference of 40-180 ⁇ m.
- the circumference is defined in macro scale.
- the circumference can be enlarged micro-scale by adding roughness to the wire, in order to control the neointimal growth and making the circumference in micro scale longer while keeping the macro scale the same.
- the surface cross section of the filament would be in the range 75-3000 ⁇ m 2 preferably 300-1300 ⁇ m 2 .
- the windows formed in the braided tube would also be preferably within a predetermined range such as to reduce the blood-flow in the portion of the braided tube applied over the aneurysm, but maintain sufficient blood flow in any perforating or branch vessels in the vicinity of the aneurysm.
- the length of the window i.e., its long dimension as shown at W L in FIG. 1 a
- the braid angle ( ⁇ , FIG. 1 a ) would preferably be within the range of 150-20°, more preferably 80-40° for high radial force and 100-140° for low radial force, in the expanded condition of the braided tube.
- the diameter and length of the braided tube in its normal, expanded condition will vary according to the location and anatomical dimensions at the particular site of the implantation.
- the windows are globally (but not necessary locally) uniform in size such that any portion of the device can be placed across the neck of the aneurysm to reduce the blood flow thereto, while the remaining portions of the device firmly contact the walls of the blood vessel and securely anchors the device within the blood vessel.
- the filaments can be made of any suitable material which are bio-compatible and which can be worked into a braid.
- Bio-compatible means any material that can be safely introduced and implanted in human or animal bodies for indefinite periods of time without causing any significant physiological damage.
- the filaments are made of a material selected from among the 316L stainless steel, tantalum, and super elastic Nitinol, cobalt base alloy, polymer or any other suitable metal or metal combination.
- the filament can be coated with bio-compatible coatings [Ulrich Sigwart, “Endoluminal Stenting”, W. B. Saunders Company Ltd., London, 1996]. It is possible to use a combination of several filament materials in one device and combinations of several materials in one filament.
- a portion of a lumen e.g., an artery, varying significantly in diameter along its length.
- a constant diameter braided tube device is inserted into such a variable-diameter lumen, this may result in a defective anchoring of the device at the larger diameter portion of the lumen, and in a possible risk of the migration of the device within the lumen.
- This problem can be easily overcome in several ways, e.g., by creating braided devices with variable diameters along their longitudinal axis, as described in the above-cited International Publication No. WO 02/05729, the contents of which are incorporated herein by reference.
- FIG. 7 diagrammatically illustrates the braided tube device, therein generally designated 20 , implanted in a blood vessel 22 having an aneurysm 24 in a region of a blood vessel 22 having a plurality of perforating vessels 26 .
- the braided tube device 20 is introduced, in its contracted condition, into the blood vessel 22 and is manipulated to the implantation site by a microcatheter 28 where it is expanded such that it overlies the neck 30 of the aneurysm sac 24 and the perforating vessels 26 .
- the braided tube is thus firmly bonded, by its expansion, to the inner surfaces of the blood vessel 20 .
- the braided tube device 20 is constructed such that, in its expanded deployed condition as shown in FIG.
- FIGS. 8, 9 and 10 illustrate the use of the braided tube device, generally designated 30 , to treat an aneurysm in a blood vessel at or proximate to a bifurcation leading to one or more branch vessels.
- FIG. 8 illustrates the braided tube device 30 implanted in a blood vessel 32 having an aneurysm 34 at the bifurcation leading to two branch vessels 36 , 38 .
- the braided tube device 30 is deployed with one end embedded in the blood vessel 32 and the opposite end embedded within the branch vessel 38 , so as to produce a reduced blood flow to the aneurysm sac 34 , and also to the branch vessel 36 .
- the reduced blood flow to the aneurysm sac 34 is sufficient to reduce the possibility of rupture of the sac, the reduced blood flow to the branch 36 is not sufficient so as to be likely to cause damage to the tissues supplied by that branch vessel.
- FIG. 9 illustrates a variation wherein one end of the braided tube 30 is bonded within the main blood vessel 32 , and the opposite end is bonded within the branch vessel 36 .
- the aneurysm sac 34 will also have a reduced supply of blood such as to reduce the possibility of its rupture, while the branch vessel 38 will have its blood supply reduced but not to the point of causing damage to the tissues supplied by that vessel.
- FIG. 10 illustrates the variation wherein the opposite ends of the braided tube 30 are embedded in the two branch vessels 36 , 38 at the bifurcation.
- the blood supply to the aneurysm sac 34 will also be reduced, but the blood supply to both branch vessels 36 , 38 will be reduced but not sufficient to cause damage to the tissues supplied by those branch vessels.
- a porosity index of 70% can achieved by changing the filament diameter and the number of filaments as follows: Windows Artery Braiding Number Filaments Inscribed Porosity Diameter Angle of Fil- Width Diameter Index # [mm] [deg] aments [ ⁇ m] [ ⁇ m] [%] 1(a) 3 90 108 20 100 70 1(b) 3 90 78 27 140 70 1(c) 3 90 62 35 180 70
- the porosity index can changes by changing the number of filaments as follows: Windows Artery Braiding Number Filament Inscribed Porosity Diameter Angle of Fil- Diameter Diameter Index # [mm] [deg] aments [ ⁇ m] [ ⁇ m] [%] 2(a) 3 90 64 27 180 75 2(b) 3 90 108 27 140 70 2(c) 3 90 110 27 80 60
- the porosity index can changed by changing the filament diameter as?follows: Windows Artery Braiding Number Filaments Inscribed Porosity Diameter Angle of Fil- Diameter Diameter Index # [mm] [deg] aments [ ⁇ m] [ ⁇ m] [%] 4(a) 3 90 78 20 150 77 4(b) 3 90 78 27 140 70 4(c) 3 90 78 35 130 63
- the device could be composed of multiple tubular meshes, lying one above the other in layer-like formations.
- the device could include a plurality of groups of filaments in the longitudinal and/or circumferential direction.
- the invention could be implemented with respect to many of the other variations and applications described in the above-cited International Application PCT IL01/00624 incorporated herein by reference.
Abstract
Description
- The present invention is related to Provisional Application No. 60/332,013 filed 23 Nov. 2001, the contents of which are incorporated herein by reference, and claims the priority date of that application.
- The present invention relates to intraluminal devices implantable in a blood vessel for the treatment of aneurysms especially brain aneurysms. The invention also relates to methods of treating aneurysms using such intraluminal devices.
- A number of publications as listed at the end of this specification are incorporated herein by reference in their entireties for background information and are numerically referenced in the following text:
- Intracranial aneurysms are the main cause of nontraumatic subarachnoid hemorrhage and are responsible for about 25% of all deaths relating to cerebrovascular events. Autopsy studies show that the overall frequency of intracranial aneurysms in the general population is approximately 5 percent and suggest that 10 to 15 million persons in the United States have or will have intracranial aneurysms [1]. In approximately 15,000 cases (6 cases per 100,000 persons per year), intracranial aneurysms rupture every year in North America [2]. Rupture of intracranial aneurysms leads to subarachnoid aneurysmal hemorrhage (SAH) which has a 30-day mortality rate of 45%, and results in approximately half the survivors sustaining irreversible brain damage [1, 2].
- The primary goal of treatments for intracranial aneurysm is prevention of the rupture of the aneurysms, thereby preventing bleeding or rebleeding. At the present time, three general methods of treatment exist. These can be grouped according to their approach: extravascular, endovascular, and extra-endovascular.
- The extravascular approach involves surgery or microsurgery of the aneurysm. One surgical procedure is to apply a metallic clip or a suture-ligation across the artery feeding the aneurysm (neck), thereby allowing the aneurysm to clot off and hopefully shrink. Another surgical procedure is to “surgically reconstruct” the aneurysmal portion of the artery, by surgically cut out the aneurysm and repairing the vessel by using a natural or synthetic vessel graft. Both of these surgical procedures typically require general anesthesia, craniotomy, brain retraction, and dissection of the arachnoid around the neck of the aneurysm.
- Surgical treatment of vascular intracranial aneurysm is accompanied by a mortality rate of 3.8% and a morbidity rate of 10.9% [3]. Because of the high mortality and morbidity rates, and because the condition of many patients does not permit them to undergo an open operation, the surgical procedure is often delayed or not practical. For this reason the prior art has sought alternative means of treatment.
- The development of microcatheters made possible the use of endovascular (catheter-based) procedures. The major advantage of the endovascular procedures is that they do not require the use of open surgery. They are generally more beneficial and have much lower mortality and morbidity rates than the extravascular procedures.
- Many variations of endovascular procedures exist of which some of the more important are the following:
- 1. Placement of embolic material, such as metallic microcoils or spherical beads, inside the aneurysm sac in order to form a mass within this sac which will slow the blood flow and generally encourage the aneurysm to clot off and to shrink. To accomplish this procedure, a microcatheter is guided through the cerebral arteries until the site of the aneurysm is reached. The distal tip of the microcatheter is than placed within the sac of the aneurysm, and the embolic material is injected into the sac of the aneurysm. Typical microcatheters suitable for this procedure are disclosed in U.S. Pat. Nos. 5,853,418; 6,066,133; 6,165,198 and 6,168,592.
- Widespread, long-term experience with this technique has shown several risks and limitations. The method has 4% morbidity and 1% mortality rate and achieves complete aneurysm occlusion in only 52% to 78% of the cases in which it is employed. The relatively low success rate is due to technical limitations (e.g., coil flexibility, shape, and dimensions) which prevent tight packing of the sac of the aneurysm, especially aneurysms with wide necks [3]. Other difficulties are associated with the presence of preexisting thrombus within the aneurysm cavity, which may be sheared off into the parent trunk leading to parent artery occlusion. Also aneurysm perforation may occur during placement of coils into the aneurysm. Additionally, occurrence of coil movement and compaction may foster aneurysm revascularization or growth.
- 2. Another endovascular technique for treating aneurysms involves inserting a detachable balloon into the sac of the aneurysm using a microcatheter. The detachable balloon is then inflated using embolic material, such as a liquid polymer material or microcoils. The balloon is then detached from the microcatheter and left within the sac of the aneurysm in an attempt to fill the sac and to form a thrombotic mass inside the aneurysm.
- One of the disadvantages of this method is that detachable balloons, when inflated, typically do not conform to the interior configuration of the aneurysm sac. Instead, the aneurysm sac is forced to conform to the exterior surface of the detachable balloon. Thus, there is an increased risk that the detachable balloon will rupture the sac of the aneurysm.
- 3. Stent technology has been applied to the intracranial vasculature. The use of this technology has been limited until recently by the lack of available stents and stent delivery systems capable of safe and effective navigation through the intercranial vessels. The use of such stents is particularly difficult with respect to aneurysms in head blood vessels because of the number of perforating vessels in such blood vessels, and thereby the increased danger that one or more perforating vessels may be in the vicinity of such an aneurysm. The same is true with respect to bifurcations of a blood vessel splitting into one or more branch vessels, which may also be in the vicinity of an aneurysm. Where the blood supply to an aneurysm is to be reduced, it is critical that the blood supply to such perforating vessel or branch vessels, in the vicinity of the aneurysm not be unduly reduced to the degree causing damage to the tissues supplied with blood by such perforating or branch vessels.
- Thus, there is a serious danger that the placement of a conventional endovascular stent within the parent artery across the aneurysm neck to reduce blood flow to the aneurysm, to promote intra-aneurysm stasis and thrombosis [4,5].
- Stents having portions of different permeabilities are disclosed, for example, in McCrory U.S. Pat. No. 5,951,599, Brown et al U.S. Pat. No. 6,093,199, Wallsten U.S. Pat. No. 4,954,126, and Dubrul U.S. Pat. No. 6,258,115.
- The McCrory patent discloses a braided stent having a first portion with a relatively high porosity index so as to be highly permeable to blood flow, and a second portion of lower porosity index so as to be less permeable to blood flow. When the stent is deployed, the portion of low permeability is located to overlie the neck of the aneurysm, and the portion of high permeability is spaced from the neck of the aneurysm. A braided stent construction with different porosities is also disclosed in the Dubrul patent.
- Brown et al, on the other hand, discloses an intraluminal device or stent comprising a diverter, in the form of a low-permeability foam pad, to overlie the neck of the aneurysm, straddled on its opposite sides by a pair of high-permeability coil elements for anchoring the device in the blood vessel.
- Wallsten U.S. Pat. No. 4,954,126, discloses a braided tube intraluminal device for use in various applications, one of which applications is to apply a graft to treat an aneurysm (FIG. 9). In this case, the complete braided tube would have high permeability with respect to blood flow therethrough since its function is to mount the grafts, but the graft would have low-permeability to decrease the possibility of rupture of the aneurysm.
- Delivery devices for stents for use in the intracranial vasculature are well known at the art. Typical devices are disclosed, for example, in the following U.S. Pat. Nos. 5,496,275; 5,676,659; and 6,254,628. The blood vessels in the brain are frequently as small as several millimeters, requiring that the catheters have an outside diameter as small as 2-8 French (0.66 mm to 2.64 mm).
- Technically it is very difficult to produce and accurately deploy the stents described in the above McCrory, Brown et al and Wallsten patents for treating aneurysms by using presently available delivery systems. The difficulties include not only in producing such stents of different permeabilities, but also in deploying them such that the portion of low permeability is exactly aligned with the aneurysm neck. When the device is to be implanted in a blood vessel having an aneurysm at or proximate to a perforating vessel or a bifurcation leading to a branch vessel, the portion of high permeability must be precisely located at the perforating or branch vessels in order to maintain patency in the perforating or branch vessels. Additionally, particularly in tortuous, ectatic vessels, existing stiff stents are difficult to introduce and may results in kinking such as to cause the failure of the deployment process.
- For these reasons it is apparent that there is a need for a better intraluminal device to treat an aneurysm, particularly an intracranial aneurysm.
- An object of the present invention is to provide an intraluminal device having advantages in one or more of the above respects for implantation in a blood vessel having an aneurysm in order to treat the aneurysm. Another object of the invention is to provide such an intraluminal device particularly useful for implantation in a blood vessel having an aneurysms at or proximate to one or more perforating vessels and/or a bifurcation leading to a branch vessel such as to reduce the blood flow to the aneurysms while still maintaining patency in the perforating and/or branch vessels.
- Another object of the invention is to provide an implantable intraluminal device for treating aneurysms in the intracranial vasculature that is sufficiently flexible and pliable so that it can be delivered easily to an intracranial site, deployed accurately, and then left in position to accomplish its purpose.
- A further object of the invention is to provide a method of treating aneurysms by using intraluminal devices having the above features.
- According to the present invention, there is provided an intraluminal device implantable in a blood vessel having an aneurysm therein in the vicinity of a perforating vessel, and/or of a bifurcation leading to a branch vessel, the device comprising: a mesh-like tube of bio-compatible material having an expanded condition in which the tube diameter is slightly larger than the diameter of the blood vessel in which it is to be implanted, and the tube length is sufficient to straddle the aneurysm and to be anchored to the blood vessel on the opposite sides of the aneurysm; the mesh-like tube also having a contracted condition wherein it is sufficiently flexible so as to be easily manipulatable through the blood vessel to straddle the aneurysm; the mesh-like tube, in its expanded condition, having a porosity index of 55%-80% such as to reduce the flow of blood through a wall of the mesh-like tube to the aneurysm sufficiently to decrease the possibility of rupture of the aneurysm but not to unduly reduce the blood flow to a perforating or branch vessel to the degree likely to cause significant damage to tissues supplied with blood by such perforating or branch vessel.
- Experimental evidence indicates that patency can be maintained and ischemia and infarction can be prevented if less than 50% of the ostial diameter is occluded [6].
-
- wherein: “Sm” is the actual surface covered by the mesh-like tube, and “St” is the total surface area of the mesh-like tube. The porosity index of the existing typical stents is well above 80%. In the tube devices of the present invention, however, the porosity index is not more than 85%, preferably 55-80%, more preferably 60-75%.
- In the described preferred embodiments, the mesh-like tube includes windows having an inscribed diameter of 30-480 μm, preferably 50-320 μm, in the expanded condition of the mesh-like tube.
- According to the described preferred embodiments, the mesh-like tube includes a plurality of filaments of bio-compatible material extending helically in an interlaced manner in opposite directions so as to form a braided tube. It is contemplated, however, that other mesh-like structures could be used, such as woven or knitted tubes.
- A maximum porosity index is attained when the braiding angle, in the expanded condition of the braided tube, is 90°. However, decreasing the braiding angle below 90° increases the radial force applied by the braided tube against the inner surface of the blood vessel and decreases the P.E. In cases, where low radial force is needed, the desirable low P.E. can be achieved by increasing or decreasing the braiding angle, as described below with respect to specific examples. Preferably, the braided tube has a braiding angle in the range of 20%-150% in the expanded condition of the braided tube.
- Also in the described preferred embodiments, the filaments, or at least most of them, are of circular cross-section and have a diameter of 10-60 μm, preferably 20-40 μm. The filaments could also be of non-circular cross-section, such as of square or rectangular cross-section, in which case it is preferred that they have a circumference of 40-180 μm. It is also possible to use combination of several filament diameters and filament materials in one device to achieve structural stability and/or desired radio-opacity characteristic. Preferably the braid is formed of 24-144 filaments, more preferably 62-120 filaments. The filaments may be of a suitable bio-compatible material, metal or plastic, and may include a drug or other biological coating or cladding.
- According to another aspect of the present invention, there is provided a method of treating an aneurysm in a blood vessel, which may be proximate to one or more perforating vessels and/or to a bifurcation leading to a branch vessel, by using intraluminal devices having the above combination of features.
- As will be described more particularly below, intraluminal devices constructed in accordance with the foregoing features show great promise in the treatment of aneurysms in general, and brain aneurysms in particular, since they are relatively easily manipulatable through the blood vessel to the implantation site, and when deployed in their expanded condition in the implantation site, they reduce the flow of blood to the aneurysm sufficiently to decrease the possibility of rupture thereof, while maintaining patency in any perforating or branch vessels in the vicinity of the aneurysm.
- Further features and advantages of the invention will be apparent from the description below.
- The invention is herein described, by way of example only, with reference to the accompanying drawings, wherein:
- FIGS. 1a and 1 b are side and end view, respectively, illustrating one form of intraluminal device constructed in accordance with the present invention, the device being shown in its normal, expanded condition;
- FIGS. 2a and 2 b are corresponding views but illustrating the device in its contracted, stressed condition;
- FIG. 3 more particularly illustrates the braid pattern of FIGS. 1a, 1 b and 2 a, 2 b in the expanded condition of the braided tube;
- FIG. 4 illustrates another braid pattern, wherein one filament extending in one helical direction is interwoven over and under two filaments extending in the opposite helical direction;
- FIG. 5 illustrates a further braid pattern in which two (or more) filaments extending helically in one direction are interwoven over and under two (or more) filaments extending in the opposite direction;
- FIG. 6 schematically shows the relationship between the bending rigidity of the braided tube with respect to the diameter of the filaments producing the braided tube;
- FIG. 7 schematically illustrates an intraluminal device implanted in a blood vessel having a plurality of perforating vessels in the vicinity of an aneurysm; and
- FIGS. 8, 9, and10 illustrate various manners in which an intraluminal device constructed in accordance with the present invention may be implanted in a blood vessel having an aneurysm at or proximate to a bifurcation leading to one or more branch vessels.
- It is to be understood that the drawings and the description below are provided primarily for purposes of facilitating understanding the conceptual aspects of the invention and various possible embodiments thereof, including what is presently considered to be preferred embodiments. In the interest of clarity and brevity, no attempt is made to provide more details than necessary to enable one skilled in the art, using routine skill and design, to understand and practice the described invention. It is to be further understood that the embodiments described are for purposes of example only, and that the invention is capable of being embodied in other forms and applications than described herein.
- FIGS. 1a and 1 b illustrate an intraluminal device, therein generally designated 2, constructed in accordance with the present invention in its normal or expanded condition which it assumes in a blood vessel after deployment therein; whereas FIGS. 2a and 2 b illustrate the
intraluminal device 2 of FIGS. 1a and 1 b in the contracted or stressed condition of the device which assumes to facilitate its manipulation through the blood vessel to the deployment site. - As shown particularly in FIG. 1, the intraluminal device includes a plurality of filaments of elastic and non-elastic bio-compatible material, metal or plastic, extending helically in an interlaced manner to define a braided tube. Thus, shown in FIG. 1a are a first group of filaments 3 extending helically in one direction, and a second group of filaments 4 extending helically in the opposite direction, with the two groups of filaments being interwoven such that a filament 3 overlies a filament 4 at some points as shown at 5, and underlies a filament 4 at other points as shown at 6.
- Filaments3 and 4 thus define a braided tube having a plurality of windows 7. The inscribed diameter and the length of each window are shown at Wd and WL, respectively, in the normal, expanded condition of the braided tube. These characteristics depend on, among other factors, the number of filaments and the braiding angle “α” at the cross-over points of the two groups of filaments 3, 4.
- FIG. 3 more particularly illustrates the above-described braid pattern in the expanded condition of the braided tube. Thus, as shown in FIG. 3, each filament3 a extending helically in one direction and is interwoven with one
filament 4 a extending helically in the opposite direction. Such a braid pattern is sometimes called a “one over one” pattern. FIG. 4 illustrates a “one over two” pattern, in which each filament 3 b extending helically in one direction is interwoven with twofilaments 4 b extending helically in the opposite direction. FIG. 5 illustrates a further braid pattern that may be used, in which two (or more)filaments 3 c extending helically in one direction are interwoven with two (or more) filaments 4 c extending helically in the opposite direction. - The braid pattern illustrated in FIG. 3 is of highest flexibility, whereas that illustrated in FIG. 5 is of lower flexibility but of higher strength.
- Such braided-tube intraluminal devices are well-known, for example as described in Wallsten et al, U.S. Pat. No. 5,061,275 and Wallsten U.S. Pat. No. 4,954,126, the contents of which are incorporated herein by reference. They are generally used as stents for providing support to a wall of a blood vessel, for implanting a graft, e.g., to treat an aneurysm (FIG. 9 of the latter patent), or for other purposes. As known, the braided tube is normally formed in an expanded condition (FIGS. 1a, 1 b) having a diameter slightly larger than the diameter of the blood vessel so that when the device is deployed it becomes firmly embedded in the wall of blood vessel. However, the braided tube is capable of being stressed into a contracted condition, as shown in FIGS. 2a and 2 b, wherein the diameter of the braided tube is decreased, and its length increased, to permit manipulation of the braided tube through the blood vessel to the site of implantation.
- Further information concerning the construction and deployment of such braided-tube intraluminal devices is available in the above-cited patents, and also in Applicant's International Application PCT/IL01/00624, published 24 Jan. 2002, International Publication No. WO 02/05729, the contents of which are incorporated herein by reference.
- When such braided tubes are used as stents within blood vessels, the filaments forming the braided tube are generally of a diameter exceeding 50 μm and define windows producing a porosity index exceeding 80%. Such constructions, however, do not have the combination of flexibility to enable them to be easily manipulated through the tortuous blood vessels of the intracranial vascular system for preventing intracranial aneurysm ruptures, and blood permeability to enable them to be used for treating aneurysm at or proximate to perforating vessels, or a bifurcation leading to a branch vessel. These problems were sought to be overcome in the above-cited McCrory U.S. Pat. No. 5,951,599, Brown et al U.S. Pat. No. 6,093,199 and Wallsten U.S. Pat. No. 4,954,126, in producing braided tubes having a high-permeability portion to be deployed in the blood vessel and a low-permeability portion aligned with the aneurysm, but as indicated above such braided tubes constructions are difficult to produce, difficult to manipulate through the blood vessel, and difficult to accurately deploy at the site of the aneurysm.
- According to the present invention, the filaments making up the braided tube are of a sufficiently small size in cross-section and define windows of a size such that the braided tube, when in its contracted condition, is sufficiently flexible so as to be easily manipulatable through the blood vessel to straddle the aneurysm; and when in its expanded condition straddling the aneurysm, reduces the flow of blood through the braided tube to the aneurysm sufficiently to decrease the possibility of rupture of the aneurysm. When the device is implantable in a blood vessel having an aneurysm at or proximate to one or more perforating vessels, or a bifurcation leading to a branch vessel, the windows defined by the filaments of the braided tube are such as to reduce the flow of blood therethrough to the aneurysm to decrease the possibility of rupturing it, but not to unduly reduce the blood flow to the perforating or branch vessels to the degree likely to cause damage to tissues supplied with blood by such vessels. As indicated earlier, experimental evidence indicates that patency can be maintained, and ischemia and infarction can be prevented, if less than 50% of the ostial diameter of the branch vessel is occluded.
- FIG. 6 schematically illustrates how the bending rigidity or flexibility of a braided tube varies with the diameter of the filaments. Region A in FIG. 6 illustrates typical diameters in conventional stents used for supporting blood vessels, which region usually starts above 50 μm and extends to several hundred μm. Region B in FIG. 6 illustrates the region of filament diameters for use in constructing braided tubes in accordance with the present invention. The filament diameters in this region would be significantly smaller than in region A, preferably being 10-60 μm, more preferably 20-40 μm.
- The foregoing dimensions apply to the diameters of filaments of circular cross-section. Where the filaments are of non-circular cross-section, such as of rectangular or square cross-section, the filaments would preferably have a circumference of 40-180 μm. The circumference is defined in macro scale. The circumference can be enlarged micro-scale by adding roughness to the wire, in order to control the neointimal growth and making the circumference in micro scale longer while keeping the macro scale the same. In this case the surface cross section of the filament would be in the range 75-3000 μm2 preferably 300-1300 μm 2.
- As indicated earlier, the windows formed in the braided tube would also be preferably within a predetermined range such as to reduce the blood-flow in the portion of the braided tube applied over the aneurysm, but maintain sufficient blood flow in any perforating or branch vessels in the vicinity of the aneurysm. Preferably the length of the window, i.e., its long dimension as shown at WL in FIG. 1a, would be within the range of 50-400 μm, more preferably 80-300 μm, in the expanded condition of the braided tube. Also, the braid angle (α, FIG. 1a) would preferably be within the range of 150-20°, more preferably 80-40° for high radial force and 100-140° for low radial force, in the expanded condition of the braided tube.
- The diameter and length of the braided tube in its normal, expanded condition, will vary according to the location and anatomical dimensions at the particular site of the implantation. Preferably, the windows are globally (but not necessary locally) uniform in size such that any portion of the device can be placed across the neck of the aneurysm to reduce the blood flow thereto, while the remaining portions of the device firmly contact the walls of the blood vessel and securely anchors the device within the blood vessel.
- The filaments can be made of any suitable material which are bio-compatible and which can be worked into a braid. Bio-compatible means any material that can be safely introduced and implanted in human or animal bodies for indefinite periods of time without causing any significant physiological damage. Preferably, the filaments are made of a material selected from among the 316L stainless steel, tantalum, and super elastic Nitinol, cobalt base alloy, polymer or any other suitable metal or metal combination. The filament can be coated with bio-compatible coatings [Ulrich Sigwart, “Endoluminal Stenting”, W. B. Saunders Company Ltd., London, 1996]. It is possible to use a combination of several filament materials in one device and combinations of several materials in one filament.
- In some situations, it may be desired to implant the device in a portion of a lumen, e.g., an artery, varying significantly in diameter along its length. As will be appreciated, if a constant diameter braided tube device is inserted into such a variable-diameter lumen, this may result in a defective anchoring of the device at the larger diameter portion of the lumen, and in a possible risk of the migration of the device within the lumen. This problem can be easily overcome in several ways, e.g., by creating braided devices with variable diameters along their longitudinal axis, as described in the above-cited International Publication No. WO 02/05729, the contents of which are incorporated herein by reference.
- FIG. 7 diagrammatically illustrates the braided tube device, therein generally designated20, implanted in a
blood vessel 22 having an aneurysm 24 in a region of ablood vessel 22 having a plurality of perforatingvessels 26. Thebraided tube device 20 is introduced, in its contracted condition, into theblood vessel 22 and is manipulated to the implantation site by amicrocatheter 28 where it is expanded such that it overlies theneck 30 of the aneurysm sac 24 and the perforatingvessels 26. The braided tube is thus firmly bonded, by its expansion, to the inner surfaces of theblood vessel 20. As described above, thebraided tube device 20 is constructed such that, in its expanded deployed condition as shown in FIG. 4, it reduces the flow of blood to the aneurysm sac 24 sufficiently to decrease the possibility of rupture thereof. While at the same time, it does not unduly reduce the flow of blood to the perforatingvessels 26 to the degree likely to cause damage to the tissue supplied by the perforating vessels. - FIGS. 8, 9 and10 illustrate the use of the braided tube device, generally designated 30, to treat an aneurysm in a blood vessel at or proximate to a bifurcation leading to one or more branch vessels.
- Thus, FIG. 8 illustrates the
braided tube device 30 implanted in ablood vessel 32 having ananeurysm 34 at the bifurcation leading to twobranch vessels braided tube device 30 is deployed with one end embedded in theblood vessel 32 and the opposite end embedded within thebranch vessel 38, so as to produce a reduced blood flow to theaneurysm sac 34, and also to thebranch vessel 36. As described earlier, however, while the reduced blood flow to theaneurysm sac 34 is sufficient to reduce the possibility of rupture of the sac, the reduced blood flow to thebranch 36 is not sufficient so as to be likely to cause damage to the tissues supplied by that branch vessel. - FIG. 9 illustrates a variation wherein one end of the
braided tube 30 is bonded within themain blood vessel 32, and the opposite end is bonded within thebranch vessel 36. In this case, theaneurysm sac 34 will also have a reduced supply of blood such as to reduce the possibility of its rupture, while thebranch vessel 38 will have its blood supply reduced but not to the point of causing damage to the tissues supplied by that vessel. - FIG. 10 illustrates the variation wherein the opposite ends of the
braided tube 30 are embedded in the twobranch vessels aneurysm sac 34 will also be reduced, but the blood supply to bothbranch vessels - Following are a number of examples of intraluminal devices constructed in accordance with the invention:
- Given:
- 1. Artery diameter=3 mm
- 2. Braiding angle α=90°
- A porosity index of 70% can achieved by changing the filament diameter and the number of filaments as follows:
Windows Artery Braiding Number Filaments Inscribed Porosity Diameter Angle of Fil- Width Diameter Index # [mm] [deg] aments [μm] [μm] [%] 1(a) 3 90 108 20 100 70 1(b) 3 90 78 27 140 70 1(c) 3 90 62 35 180 70 - Given:
- 1. Artery diameter=3 mm
- 2. Braiding angle α=90°
- 3. Filaments diameter=27 μm
- The porosity index can changes by changing the number of filaments as follows:
Windows Artery Braiding Number Filament Inscribed Porosity Diameter Angle of Fil- Diameter Diameter Index # [mm] [deg] aments [μm] [μm] [%] 2(a) 3 90 64 27 180 75 2(b) 3 90 108 27 140 70 2(c) 3 90 110 27 80 60 - Given:
- 1. Artery diameter=3 mm
- 2. Number of filaments=78
- 3. Filaments diameter=27 μm
- The porosity index can reduced from its maximum value at α=90° in # 3(a) by changing, i.e., increasing in # 3(b) or decreasing in # 3(c) the braiding angle α as follows:
Windows Artery Braiding Number Filament Inscribed Porosity Diameter Angle of Fil- diameter Diameter Index # [mm] [deg] aments [μm] [μm] [%] 3(a) 3 90 78 27 140 70 3(b) 3 106 78 27 110 65 3(c) 3 56 78 27 110 65 - Given:
- 1. Artery diameter=3 mm
- 2. Number of filaments=78
- 3. Braiding angle α=90°
- The porosity index can changed by changing the filament diameter as?follows:
Windows Artery Braiding Number Filaments Inscribed Porosity Diameter Angle of Fil- Diameter Diameter Index # [mm] [deg] aments [μm] [μm] [%] 4(a) 3 90 78 20 150 77 4(b) 3 90 78 27 140 70 4(c) 3 90 78 35 130 63 - While the invention has been described with respect to several preferred embodiments, it will be appreciated that these are set forth merely for purposes of example, and that many other variations, modifications and applications of the invention may be made.
- For example, the device could be composed of multiple tubular meshes, lying one above the other in layer-like formations. Also, the device could include a plurality of groups of filaments in the longitudinal and/or circumferential direction. Further, the invention could be implemented with respect to many of the other variations and applications described in the above-cited International Application PCT IL01/00624 incorporated herein by reference.
- 1. An International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med. 1998 Dec. 10; 339(24):1725-33: International study of unruptured intracranial aneurysms investigators; Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention.
- 2. Bederson J B, Awad I A, Wiebers D O, Piepgras D, Haley E C Jr, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C.; Recommendations for the management of patients with unruptured intracranial aneurysms: A Statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000 November; 31(11): 2742-50. No abstract available.
- 3. Wardlaw J M, White P M. The detection and management of unruptured intracranial aneurysms. Brain. 2000 February; 123 (Pt 2):205-21. Review.
- 4. Wakhloo A K, Lanzino G, Lieber B B, Hopkins L N. Stents for intracranial aneurysms: the beginning of a new endovascular era? Neurosurgery. 1998 August; 43(2):377-9.
- 5. Lieber B B, Stancampiano A P, Wakhloo A K. Alteration of hemodynamics in aneurysm models by stenting: influence of stent porosity. Ann Biomed Eng. 1997 May-June; 25(3):460-9.
- 6. Lanzino G, Wakhloo A K, Fessler R D, Hartney M L, Guterman L R, Hopkins L N. Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg. 1999 October; 91(4):538-46.
- 7. Yu S C, Zhao J B. A steady flow analysis on the stented and non-stented sidewall aneurysm models. Med Eng Phys. 1999 April; 21(3):133-41.
- 8. Marinkovic S, Gibo H, Milisavljevic M, Cetkovic M. Anatomic and clinical correlations of the lenticulostriate arteries. Clin Anat. 2001 May; 14(3):190-5.
Claims (15)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/216,356 US20030100945A1 (en) | 2001-11-23 | 2002-08-12 | Implantable intraluminal device and method of using same in treating aneurysms |
PCT/IL2002/000886 WO2003043527A2 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and method of using same in treating aneurysms |
EP02785876A EP1455679B1 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and method of using same in treating aneurysms |
AU2002349793A AU2002349793A1 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and method of using same in treating aneurysms |
EP11185045.9A EP2425800B8 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and method of using same in treating aneurysms |
ES11185045T ES2530873T3 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and procedure for its use in the treatment of aneurysms |
IL16208802A IL162088A0 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluminal device and method of using same in treating aneurysms |
ES02785876T ES2401426T3 (en) | 2001-11-23 | 2002-11-06 | Implantable intraluninar device and its use procedure in the treatment of aneurysms |
US10/910,621 US7306624B2 (en) | 2001-07-09 | 2004-08-04 | Implantable intraluminal device and method of using same in treating aneurysms |
US11/907,675 US7572290B2 (en) | 2001-07-09 | 2007-10-16 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/496,672 US7942925B2 (en) | 2001-07-09 | 2009-07-02 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/709,483 US8419787B2 (en) | 2001-11-23 | 2010-02-21 | Implantable intraluminal device and method of using same in treating aneurysms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33201301P | 2001-11-23 | 2001-11-23 | |
US10/216,356 US20030100945A1 (en) | 2001-11-23 | 2002-08-12 | Implantable intraluminal device and method of using same in treating aneurysms |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2001/000624 Continuation-In-Part WO2002005729A2 (en) | 2000-07-17 | 2001-07-09 | Implantable braided stroke preventing device and method of manufacturing |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/910,621 Continuation-In-Part US7306624B2 (en) | 2001-07-09 | 2004-08-04 | Implantable intraluminal device and method of using same in treating aneurysms |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030100945A1 true US20030100945A1 (en) | 2003-05-29 |
Family
ID=26910931
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/216,356 Abandoned US20030100945A1 (en) | 2001-07-09 | 2002-08-12 | Implantable intraluminal device and method of using same in treating aneurysms |
US10/910,621 Expired - Lifetime US7306624B2 (en) | 2001-07-09 | 2004-08-04 | Implantable intraluminal device and method of using same in treating aneurysms |
US11/907,675 Expired - Lifetime US7572290B2 (en) | 2001-07-09 | 2007-10-16 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/496,672 Expired - Fee Related US7942925B2 (en) | 2001-07-09 | 2009-07-02 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/709,483 Expired - Lifetime US8419787B2 (en) | 2001-11-23 | 2010-02-21 | Implantable intraluminal device and method of using same in treating aneurysms |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/910,621 Expired - Lifetime US7306624B2 (en) | 2001-07-09 | 2004-08-04 | Implantable intraluminal device and method of using same in treating aneurysms |
US11/907,675 Expired - Lifetime US7572290B2 (en) | 2001-07-09 | 2007-10-16 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/496,672 Expired - Fee Related US7942925B2 (en) | 2001-07-09 | 2009-07-02 | Implantable intraluminal device and method of using same in treating aneurysms |
US12/709,483 Expired - Lifetime US8419787B2 (en) | 2001-11-23 | 2010-02-21 | Implantable intraluminal device and method of using same in treating aneurysms |
Country Status (6)
Country | Link |
---|---|
US (5) | US20030100945A1 (en) |
EP (2) | EP2425800B8 (en) |
AU (1) | AU2002349793A1 (en) |
ES (2) | ES2401426T3 (en) |
IL (1) | IL162088A0 (en) |
WO (1) | WO2003043527A2 (en) |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050010281A1 (en) * | 2001-07-09 | 2005-01-13 | Ofer Yodfat | Implantable intraluminal device and method of using same in treating aneurysms |
US20050143805A1 (en) * | 2003-10-28 | 2005-06-30 | Helmut Hierlemann | Tubular implant |
US20050267568A1 (en) * | 2004-05-25 | 2005-12-01 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US20060184238A1 (en) * | 2003-07-30 | 2006-08-17 | Ralf Kaufmann | Braided stent to be implanted in a blood vessel |
US20060206199A1 (en) * | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
US20060206198A1 (en) * | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices and methods |
EP1732467A1 (en) * | 2004-03-31 | 2006-12-20 | Merlin MD PTE Ltd | A medical device |
US20070060994A1 (en) * | 2005-09-12 | 2007-03-15 | Gobran Riad H | Blood flow diverters for the treatment of intracranial aneurysms |
US20070100426A1 (en) * | 2004-03-31 | 2007-05-03 | Leon Rudakov | Medical device |
US20070255388A1 (en) * | 2004-03-31 | 2007-11-01 | Merlin Md Pte Ltd | Endovascular device with membrane |
US20080033341A1 (en) * | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
US20080038232A1 (en) * | 2003-04-27 | 2008-02-14 | Protalix Ltd. | Production of high mannose proteins in plant culture |
US20090054966A1 (en) * | 2006-02-13 | 2009-02-26 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US20090192536A1 (en) * | 2005-05-25 | 2009-07-30 | Chestnut Medical Technologies, Inc. | System and method for delivering and deploying an occluding device within a vessel |
EP2088962A2 (en) * | 2006-11-22 | 2009-08-19 | Inspiremd Ltd. | Optimized stent jacket |
US20090318947A1 (en) * | 2005-05-25 | 2009-12-24 | Chestnut Medical Technologies, Inc. | System and method for delivering and deploying an occluding device within a vessel |
US20100112700A1 (en) * | 2007-05-07 | 2010-05-06 | Protalix Ltd. | Large scale disposable bioreactor |
US20100196345A1 (en) * | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
US20100324664A1 (en) * | 2006-10-18 | 2010-12-23 | Asher Holzer | Bifurcated Stent Assemblies |
US20100324651A1 (en) * | 2006-10-18 | 2010-12-23 | Asher Holzer | Knitted Stent Jackets |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8382825B2 (en) | 2004-05-25 | 2013-02-26 | Covidien Lp | Flexible vascular occluding device |
US8394119B2 (en) | 2006-02-22 | 2013-03-12 | Covidien Lp | Stents having radiopaque mesh |
US20130218253A1 (en) * | 2012-02-13 | 2013-08-22 | J. Jordan Massey Kaufmann | Scaffold system for tissue repair |
US8617234B2 (en) * | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
EP2419048A4 (en) * | 2004-05-25 | 2014-04-09 | Covidien Lp | Vascular stenting for aneurysms |
US20140114343A1 (en) * | 2011-05-26 | 2014-04-24 | The Asan Foundation | Stent for the coil embolization of a cerebral aneurysm |
US8715317B1 (en) | 2013-07-29 | 2014-05-06 | Insera Therapeutics, Inc. | Flow diverting devices |
US8721676B1 (en) | 2013-03-15 | 2014-05-13 | Insera Therapeutics, Inc. | Slotted vascular treatment devices |
EP2837361A1 (en) | 2013-08-13 | 2015-02-18 | Cook Medical Technologies LLC | Implantable flow adjuster |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9132261B2 (en) | 2006-10-18 | 2015-09-15 | Inspiremd, Ltd. | In vivo filter assembly |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9179931B2 (en) | 2013-03-15 | 2015-11-10 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy systems |
CN105055061A (en) * | 2009-04-17 | 2015-11-18 | 泰科保健集团有限合伙公司 | Vascular stenting for aneurysms |
US9314324B2 (en) | 2013-03-15 | 2016-04-19 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9408728B2 (en) | 2009-12-21 | 2016-08-09 | Covidien Lp | Procedures for vascular occlusion |
JP2016527002A (en) * | 2013-07-17 | 2016-09-08 | レイク リージョン マニュファクチュアリング インコーポレイテッド | Device for embolism protection in large flow area |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9649187B2 (en) | 2013-05-14 | 2017-05-16 | Cook Medical Technologies Llc | Implantable flow diverter |
US9655999B2 (en) | 2013-03-12 | 2017-05-23 | Carnegie Mellon University | Coated vaso-occlusive device for treatment of aneurysms |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US9730783B2 (en) | 2010-05-25 | 2017-08-15 | The Regents Of The University Of California | Ultra-low fractional area coverage flow diverter for treating aneurysms and vascular diseases |
US20170265869A1 (en) * | 2014-08-07 | 2017-09-21 | Perflow Medical Ltd. | Aneurysm treatment device and method |
US9833309B2 (en) | 2009-03-06 | 2017-12-05 | The Regents Of The University Of California | Thin film vascular stent and biocompatible surface treatment |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
CN108210134A (en) * | 2018-02-27 | 2018-06-29 | 北京航空航天大学 | A kind of intravascular stent |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10058440B2 (en) | 2005-05-24 | 2018-08-28 | Inspiremd, Ltd. | Carotid stent apparatus and methods for treatment via body lumens |
US20190239895A1 (en) * | 2018-02-08 | 2019-08-08 | Covidien Lp | Vascular expandable devices |
CN110123502A (en) * | 2018-02-08 | 2019-08-16 | 柯惠有限合伙公司 | Blood vessel distensible devices |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10987208B2 (en) | 2012-04-06 | 2021-04-27 | Merlin Md Pte Ltd. | Devices and methods for treating an aneurysm |
US11547415B2 (en) * | 2016-07-22 | 2023-01-10 | Route 92 Medical, Inc. | Endovascular interventions in neurovascular anatomy |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US6866679B2 (en) | 2002-03-12 | 2005-03-15 | Ev3 Inc. | Everting stent and stent delivery system |
JP2010500915A (en) * | 2006-08-17 | 2010-01-14 | エヌフォーカス ニューロメディカル, インコーポレイテッド | Aneurysm isolation device |
GB0621048D0 (en) * | 2006-10-23 | 2006-11-29 | Anson Medical Ltd | Helical stent graft |
US9622888B2 (en) * | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
DE102007012964A1 (en) | 2007-03-06 | 2008-09-11 | Phenox Gmbh | Implant for influencing blood flow |
EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
US20080319533A1 (en) * | 2007-06-22 | 2008-12-25 | Neurovasx, Inc. | Aneurysm occlusion assist device |
US20090082803A1 (en) * | 2007-09-26 | 2009-03-26 | Aga Medical Corporation | Braided vascular devices having no end clamps |
US8728141B2 (en) | 2007-12-11 | 2014-05-20 | Cornell University | Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
EP3970633A1 (en) | 2008-04-21 | 2022-03-23 | Covidien LP | Braid-ball embolic devices and delivery systems |
US8974487B2 (en) | 2008-05-01 | 2015-03-10 | Aneuclose Llc | Aneurysm occlusion device |
US9597087B2 (en) * | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US8516125B2 (en) * | 2008-06-08 | 2013-08-20 | Apple Inc. | System and method for simplified data transfer |
CN102137626A (en) * | 2008-07-22 | 2011-07-27 | 微治疗公司 | Vascular remodeling device |
US20100063578A1 (en) | 2008-09-05 | 2010-03-11 | Aga Medical Corporation | Bifurcated medical device for treating a target site and associated method |
US20100131002A1 (en) * | 2008-11-24 | 2010-05-27 | Connor Robert A | Stent with a net layer to embolize and aneurysm |
CA2750222C (en) | 2009-01-22 | 2018-02-27 | Cornell University | Method and apparatus for restricting flow through the wall of a lumen |
CN101991477B (en) * | 2009-08-27 | 2014-03-26 | 上海微创医疗器械(集团)有限公司 | Vascular reconstructive support frame |
US20110087252A1 (en) * | 2009-10-08 | 2011-04-14 | Wilson-Cook Medical Inc. | Biliary decompression and anastomosis stent |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
US20110202085A1 (en) * | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
JP4499831B1 (en) * | 2010-01-22 | 2010-07-07 | 規方 田熊 | Aneurysm embolizer |
CN102740799A (en) * | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
EP2528541B1 (en) * | 2010-01-28 | 2016-05-18 | Covidien LP | Vascular remodeling device |
US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
US9867725B2 (en) | 2010-12-13 | 2018-01-16 | Microvention, Inc. | Stent |
AU2012214240B2 (en) | 2011-02-11 | 2015-03-12 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
US20120245674A1 (en) | 2011-03-25 | 2012-09-27 | Tyco Healthcare Group Lp | Vascular remodeling device |
WO2012135859A2 (en) | 2011-04-01 | 2012-10-04 | Cornell University | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
BR112013028603A2 (en) * | 2011-05-11 | 2017-01-17 | Covidien Lp | vascular remodeling device |
US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
WO2013055703A1 (en) | 2011-10-07 | 2013-04-18 | Cornell University | Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow |
US9072620B2 (en) | 2011-11-04 | 2015-07-07 | Covidien Lp | Protuberant aneurysm bridging device deployment method |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
US9072624B2 (en) | 2012-02-23 | 2015-07-07 | Covidien Lp | Luminal stenting |
US20130226278A1 (en) | 2012-02-23 | 2013-08-29 | Tyco Healthcare Group Lp | Methods and apparatus for luminal stenting |
DE202013012692U1 (en) | 2012-03-16 | 2018-07-30 | Microvention, Inc. | Stent and stent delivery device |
US9393136B2 (en) | 2012-03-27 | 2016-07-19 | Medtronic Vascular, Inc. | Variable zone high metal to vessel ratio stent and method |
US8911490B2 (en) | 2012-03-27 | 2014-12-16 | Medtronic Vascular, Inc. | Integrated mesh high metal to vessel ratio stent and method |
US9005270B2 (en) | 2012-03-27 | 2015-04-14 | Medtronic Vascular, Inc. | High metal to vessel ratio stent and method |
US9078659B2 (en) | 2012-04-23 | 2015-07-14 | Covidien Lp | Delivery system with hooks for resheathability |
CN104736102B (en) | 2012-05-31 | 2018-05-18 | 标枪医疗有限公司 | System, method and apparatus for embolism protection |
US9724222B2 (en) | 2012-07-20 | 2017-08-08 | Covidien Lp | Resheathable stent delivery system |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US20140180377A1 (en) * | 2012-12-20 | 2014-06-26 | Penumbra, Inc. | Aneurysm occlusion system and method |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
CN105007864B (en) | 2013-01-18 | 2017-03-22 | 标枪医疗有限公司 | Monofilament implants and systems for delivery thereof |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US20140277397A1 (en) | 2013-03-12 | 2014-09-18 | DePuy Synthes Products, LLC | Variable porosity intravascular implant and manufacturing method |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US9320592B2 (en) * | 2013-03-15 | 2016-04-26 | Covidien Lp | Coated medical devices and methods of making and using same |
US9545301B2 (en) | 2013-03-15 | 2017-01-17 | Covidien Lp | Coated medical devices and methods of making and using same |
CN105142545B (en) | 2013-03-15 | 2018-04-06 | 柯惠有限合伙公司 | Locking device |
US10130500B2 (en) | 2013-07-25 | 2018-11-20 | Covidien Lp | Methods and apparatus for luminal stenting |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US8968383B1 (en) | 2013-08-27 | 2015-03-03 | Covidien Lp | Delivery of medical devices |
US9782186B2 (en) | 2013-08-27 | 2017-10-10 | Covidien Lp | Vascular intervention system |
US9668890B2 (en) | 2013-11-22 | 2017-06-06 | Covidien Lp | Anti-thrombogenic medical devices and methods |
US9592110B1 (en) | 2013-12-06 | 2017-03-14 | Javelin Medical, Ltd. | Systems and methods for implant delivery |
JP6661539B2 (en) | 2013-12-20 | 2020-03-11 | テルモ株式会社 | Vessel closure |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US9789228B2 (en) | 2014-12-11 | 2017-10-17 | Covidien Lp | Antimicrobial coatings for medical devices and processes for preparing such coatings |
US11013833B2 (en) | 2015-08-03 | 2021-05-25 | Advanced Endovascular Therapeutics | Coatings for medical devices |
CA2995407A1 (en) * | 2015-09-09 | 2017-03-16 | Frid Mind Technologies | Bifurcated 3d filter assembly for prevention of stroke |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US10076428B2 (en) | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
JP7222886B2 (en) | 2016-10-21 | 2023-02-15 | ジャベリン メディカル リミテッド | Systems, methods, and devices for embolic protection |
US10376396B2 (en) | 2017-01-19 | 2019-08-13 | Covidien Lp | Coupling units for medical device delivery systems |
US11191976B2 (en) | 2017-05-19 | 2021-12-07 | Prometheus Therapeutics Inc. | Devices and methods for repair of a selected blood vessel or part thereof and rapid healing of injured internal body cavity walls |
US11103252B2 (en) * | 2018-01-23 | 2021-08-31 | Swaminathan Jayaraman | Device to treat vascular defect and method of making the same |
US10786377B2 (en) | 2018-04-12 | 2020-09-29 | Covidien Lp | Medical device delivery |
US11123209B2 (en) | 2018-04-12 | 2021-09-21 | Covidien Lp | Medical device delivery |
US11413176B2 (en) | 2018-04-12 | 2022-08-16 | Covidien Lp | Medical device delivery |
US11071637B2 (en) | 2018-04-12 | 2021-07-27 | Covidien Lp | Medical device delivery |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
US10456280B1 (en) * | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US11564692B2 (en) | 2018-11-01 | 2023-01-31 | Terumo Corporation | Occlusion systems |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
JP2022525316A (en) | 2019-03-15 | 2022-05-12 | シークエント メディカル インコーポレイテッド | Filamentous devices for the treatment of angiopathy |
EP3908208A4 (en) | 2019-03-15 | 2022-10-19 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
US11317921B2 (en) | 2019-03-15 | 2022-05-03 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
CN110025414B (en) * | 2019-04-16 | 2021-07-20 | 吉林大学中日联谊医院 | Braided vascular stent and preparation method thereof |
US11413174B2 (en) | 2019-06-26 | 2022-08-16 | Covidien Lp | Core assembly for medical device delivery systems |
Family Cites Families (197)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US467993A (en) | 1892-02-02 | Alfred jorgensen | ||
US2147271A (en) | 1937-07-16 | 1939-02-14 | Schwarz Lab Inc | Pure yeast culture apparatus |
US2341259A (en) | 1941-01-22 | 1944-02-08 | Lummus Co | Inoculating method and apparatus |
US2836434A (en) | 1952-08-21 | 1958-05-27 | Separator Ab | Arrangement for sterile interconnection and sealing of apparatuses in a plant for instance for cultivation of bacteria |
DE1415406B1 (en) * | 1958-04-30 | 1970-08-20 | Siemens Ag | Ceramic resistor with a high positive temperature coefficient of its total resistance value |
US3201327A (en) | 1962-08-21 | 1965-08-17 | Sun Oil Co | Fermentation apparatus and process |
SE347015B (en) | 1966-10-06 | 1972-07-24 | Sanraku Ocean Co | |
US3468520A (en) | 1967-05-12 | 1969-09-23 | American Cyanamid Co | Combination agitation and transfer unit for suspended cells |
US3504185A (en) | 1968-05-09 | 1970-03-31 | Univ Syracuse Res Corp | Apparatus for measuring and controlling cell population density in a liquid medium |
GB1284077A (en) | 1968-10-18 | 1972-08-02 | British Petroleum Co | Process and apparatus for the cultivation of micro-organisms |
US3540700A (en) | 1969-01-24 | 1970-11-17 | New Brunswick Scientific Co | Rotary processing apparatus |
DE2059931C3 (en) | 1970-12-05 | 1973-10-18 | Knapsack Ag, 5033 Huerth-Knapsack | Method for preventing foam eruptions from closed reaction spaces |
US3793154A (en) | 1970-12-21 | 1974-02-19 | Univ St Johns | Apparatus for gaseous environmental control of batch cultures of micro-organisms |
US3950227A (en) | 1970-12-21 | 1976-04-13 | St. John's University | Batch method of establishing and maintaining a controlled aerobic environment for a microbial culture |
CS192067B1 (en) | 1975-12-02 | 1979-08-31 | Drahoslav Pravda | Separation blood bag for the sterile preparation of the blood serum for single use |
US4179339A (en) | 1977-03-02 | 1979-12-18 | Olympus Optical Company, Ltd. | Liquid feeder for automatic culture apparatus |
US4228243A (en) | 1978-07-13 | 1980-10-14 | Toray Industries, Inc. | Cell culture propagation apparatus |
US4328317A (en) | 1980-03-31 | 1982-05-04 | Solargizer International, Inc. | Continuous chemical conversion or fermentation apparatus |
DE3133314A1 (en) | 1981-08-22 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "DEVICE FOR DISPERGING A SECOND PHASE IN A FIRST PHASE" |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4519984A (en) | 1982-01-18 | 1985-05-28 | Phillips Petroleum Company | Apparatus for carrying out sparged reaction |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
CH663422A5 (en) | 1982-05-27 | 1987-12-15 | Chemap Ag | METHOD AND FERMENTER FOR GROWING TISSUE CELLS. |
US4643184A (en) * | 1982-09-29 | 1987-02-17 | Mobin Uddin Kazi | Embolus trap |
US4708938A (en) | 1984-04-30 | 1987-11-24 | Hickinbotham Winemakers Pty. Ltd. | Alcoholic fermentation |
DK151404C (en) | 1984-05-23 | 1988-07-18 | Cook Europ Aps William | FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD |
EP0183372A1 (en) | 1984-10-19 | 1986-06-04 | RAYCHEM CORPORATION (a Delaware corporation) | Prosthetic stent |
US4577631A (en) * | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
EP0200792B1 (en) | 1985-02-01 | 1990-05-09 | Herbert Prof. Dr.-Ing. Märkl | Foil fermenter |
US4668632A (en) | 1985-02-06 | 1987-05-26 | Vxr, Inc. | Sparger and apparatus for and method of growing cells |
SE450809B (en) * | 1985-04-10 | 1987-08-03 | Medinvent Sa | PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS |
US5372945A (en) | 1985-06-06 | 1994-12-13 | Alchas; Paul G. | Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product |
US4713345A (en) | 1985-07-29 | 1987-12-15 | Grain Processing Corporation | Fermentation methods and apparatus |
EP0224962A1 (en) | 1985-11-25 | 1987-06-10 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Apparatus for the continuous cultivation of microorganisms in a culture liquid |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US5166072A (en) | 1986-06-26 | 1992-11-24 | Bayer Aktiengesellschaft | Apparatus for the cultivation of immobilized micro-organisms |
US4717668A (en) | 1986-12-12 | 1988-01-05 | Baxter Travenol Laboratories, Inc. | Plastic roller bottle for suspension cultures |
US5081036A (en) | 1987-01-23 | 1992-01-14 | Hoffmann-La Roche Inc. | Method and apparatus for cell culture |
US4908315A (en) | 1987-03-04 | 1990-03-13 | Agristar, Inc. | Integument and method for micropropagation and tissue culturing |
GB2202549A (en) | 1987-03-20 | 1988-09-28 | Philip John Whitney | Foldable fermenter |
US6846968B1 (en) | 1988-02-26 | 2005-01-25 | Large Scale Biology Corporation | Production of lysosomal enzymes in plants by transient expression |
IL86442A (en) | 1988-05-19 | 1992-02-16 | Plant Biotec Ltd | Air lift fermenter formed from flexible plastic sheets |
DE3823711C1 (en) | 1988-07-13 | 1990-04-12 | Chemap Ag, Volketswil, Ch | |
US4931401A (en) | 1988-09-01 | 1990-06-05 | La Societe De Recherche Snc Inc. | Bioreactor |
US5549892A (en) | 1988-12-23 | 1996-08-27 | Genzyme Corporation | Enhanced in vivo uptake of glucocerebrosidase |
US5073491A (en) | 1988-12-23 | 1991-12-17 | Hoffman-La Roche Inc. | Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors |
US5188946A (en) | 1989-01-26 | 1993-02-23 | Biocontrol Systems Incorporated | Process and device for sequential microbial enrichment in a single apparatus |
US5100801A (en) | 1989-01-26 | 1992-03-31 | Biocontrol Systems, Inc. | Device for sequential microbial enrichment in a single apparatus |
US5843089A (en) * | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
US6083220A (en) | 1990-03-13 | 2000-07-04 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
DE59109267D1 (en) | 1990-06-15 | 2005-04-07 | Syngenta Participations Ag | New signal sequences |
EP0471947A1 (en) | 1990-06-29 | 1992-02-26 | Sekisui Chemical Co., Ltd. | Culture bag |
US5240598A (en) | 1990-09-18 | 1993-08-31 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Microbubble generator for the transfer of oxygen to microbial inocula and microbubble generator immobilized cell reactor |
US5367110A (en) | 1990-11-13 | 1994-11-22 | Yeda Research And Development Co. Ltd. | Transgenic plants overproducing threonine and lysine |
AT394576B (en) | 1991-01-16 | 1992-05-11 | Vogelbusch Gmbh | REACTOR FOR CARRYING OUT BIOLOGICAL REACTIONS BY MEANS OF BIOCATALYSTS |
US5350398A (en) * | 1991-05-13 | 1994-09-27 | Dusan Pavcnik | Self-expanding filter for percutaneous insertion |
CA2068483A1 (en) | 1991-05-15 | 1992-11-16 | Motasim Mahmoud Sirhan | Low profile dilatation catheter |
US5304220A (en) * | 1991-07-03 | 1994-04-19 | Maginot Thomas J | Method and apparatus for implanting a graft prosthesis in the body of a patient |
US5415630A (en) * | 1991-07-17 | 1995-05-16 | Gory; Pierre | Method for removably implanting a blood filter in a vein of the human body |
US5612188A (en) | 1991-11-25 | 1997-03-18 | Cornell Research Foundation, Inc. | Automated, multicompartmental cell culture system |
US5267791A (en) | 1991-12-13 | 1993-12-07 | Corning Incorporated | Suspended cell culture stirring vessel closure and apparatus |
JPH05219834A (en) | 1992-02-14 | 1993-08-31 | Fumiko Kobayashi | Disposable culture bag and culture process |
IL102189A (en) | 1992-06-12 | 1995-07-31 | Univ Ben Gurion | Microorganism growth apparatus |
US5324304A (en) * | 1992-06-18 | 1994-06-28 | William Cook Europe A/S | Introduction catheter set for a collapsible self-expandable implant |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5383392A (en) | 1993-03-16 | 1995-01-24 | Ward Holding Company, Inc. | Sheet registration control |
US5409833A (en) | 1993-07-01 | 1995-04-25 | Baxter International Inc. | Microvessel cell isolation apparatus |
US5464449A (en) * | 1993-07-08 | 1995-11-07 | Thomas J. Fogarty | Internal graft prosthesis and delivery system |
US5342781A (en) | 1993-07-15 | 1994-08-30 | Su Wei Wen W | External-loop perfusion air-lift bioreactor |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
DE69432359T2 (en) | 1993-11-12 | 2003-12-24 | Micro Interventional Systems P | CATHETER WITH SMALL DIAMETER AND HIGH TORQUE |
US5443497A (en) * | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
US5549626A (en) | 1994-12-23 | 1996-08-27 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Vena caval filter |
GB2298577B (en) * | 1995-03-09 | 1999-02-17 | Univ Bristol | Arteriovenous bypass grafting |
US5725568A (en) | 1995-06-27 | 1998-03-10 | Scimed Life Systems, Inc. | Method and device for recanalizing and grafting arteries |
US5853418A (en) | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
US5769816A (en) * | 1995-11-07 | 1998-06-23 | Embol-X, Inc. | Cannula with associated filter |
ATE218052T1 (en) | 1995-11-27 | 2002-06-15 | Schneider Europ Gmbh | STENT FOR USE IN A PHYSICAL PASSAGE |
US6576009B2 (en) * | 1995-12-01 | 2003-06-10 | Medtronic Ave, Inc. | Bifurcated intraluminal prostheses construction and methods |
US5871537A (en) | 1996-02-13 | 1999-02-16 | Scimed Life Systems, Inc. | Endovascular apparatus |
US5891191A (en) | 1996-04-30 | 1999-04-06 | Schneider (Usa) Inc | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5800514A (en) | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
IL119310A (en) | 1996-09-26 | 1999-07-14 | Metabogal Ltd | Cell/tissue culturing device and method |
IL155588A0 (en) | 2003-04-27 | 2003-11-23 | Metabogal Ltd | Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby |
US20050032211A1 (en) | 1996-09-26 | 2005-02-10 | Metabogal Ltd. | Cell/tissue culturing device, system and method |
US5876367A (en) * | 1996-12-05 | 1999-03-02 | Embol-X, Inc. | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
US5807330A (en) * | 1996-12-16 | 1998-09-15 | University Of Southern California | Angioplasty catheter |
US5919224A (en) | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US5814064A (en) | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US5817126A (en) | 1997-03-17 | 1998-10-06 | Surface Genesis, Inc. | Compound stent |
US5853419A (en) | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US6048360A (en) * | 1997-03-18 | 2000-04-11 | Endotex Interventional Systems, Inc. | Methods of making and using coiled sheet graft for single and bifurcated lumens |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US6027529A (en) * | 1997-04-15 | 2000-02-22 | Schneider (Usa) Inc | Protheses with selectively welded crossing strands |
WO1998047447A1 (en) * | 1997-04-23 | 1998-10-29 | Dubrul William R | Bifurcated stent and distal protection system |
US6258120B1 (en) * | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
CA2235911C (en) | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
CH691846A5 (en) | 1997-06-20 | 2001-11-15 | Ecole Polytech | intravascular implant expansion deflector. |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
AU8772198A (en) | 1997-08-05 | 1999-03-08 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge |
US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6190913B1 (en) | 1997-08-12 | 2001-02-20 | Vijay Singh | Method for culturing cells using wave-induced agitation |
US6086577A (en) | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US5855599A (en) * | 1997-09-02 | 1999-01-05 | Sitek, Inc. | Silicon micro machined occlusion implant |
US5941896A (en) * | 1997-09-08 | 1999-08-24 | Montefiore Hospital And Medical Center | Filter and method for trapping emboli during endovascular procedures |
US6030414A (en) * | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
US6022374A (en) | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US5976169A (en) | 1997-12-16 | 1999-11-02 | Cardiovasc, Inc. | Stent with silver coating and method |
US5964798A (en) | 1997-12-16 | 1999-10-12 | Cardiovasc, Inc. | Stent having high radial strength |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US6096546A (en) | 1998-01-30 | 2000-08-01 | Board Of Trustees, Rutgers, The State University Of New Jersey | Methods for recovering polypeptides from plants and portions thereof |
ATE313304T1 (en) * | 1998-02-12 | 2006-01-15 | Thomas R Marotta | ENDOVASCULAR PROSTHESIS |
IL124958A0 (en) | 1998-06-16 | 1999-01-26 | Yodfat Ofer | Implantable blood filtering device |
US5928261A (en) * | 1998-06-29 | 1999-07-27 | Ruiz; Carlos E. | Removable vascular filter, catheter system and methods of use |
US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
JP3689802B2 (en) | 1998-08-06 | 2005-08-31 | 株式会社ロッテ | Tooth enamel remineralization accelerator, oral composition and food and drink |
US6117117A (en) * | 1998-08-24 | 2000-09-12 | Advanced Cardiovascular Systems, Inc. | Bifurcated catheter assembly |
WO2000011953A1 (en) | 1998-09-01 | 2000-03-09 | Penn State Research Foundation | Method and apparatus for aseptic growth or processing of biomass |
AU5905599A (en) | 1998-09-04 | 2000-03-27 | Boston Scientific Limited | Detachable aneurysm neck closure patch |
JP3689803B2 (en) | 1998-10-20 | 2005-08-31 | 株式会社ロッテ | Tooth enamel remineralization accelerator, oral composition and food and drink |
US6540780B1 (en) | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
US6528063B2 (en) | 1999-01-04 | 2003-03-04 | Rahan Meristem | Recombinant vaccines against IBDV |
US6432698B1 (en) | 1999-01-06 | 2002-08-13 | Rutgers, The State University | Disposable bioreactor for culturing microorganisms and cells |
WO2000044309A2 (en) * | 1999-02-01 | 2000-08-03 | Board Of Regents, The University Of Texas System | Woven bifurcated and trifurcated stents and methods for making the same |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US6673089B1 (en) * | 1999-03-11 | 2004-01-06 | Mindguard Ltd. | Implantable stroke treating device |
IL128938A0 (en) * | 1999-03-11 | 2000-02-17 | Mind Guard Ltd | Implantable stroke treating device |
US20040167613A1 (en) | 1999-03-11 | 2004-08-26 | Ofer Yodfat | Implantable stroke prevention device |
US6146370A (en) * | 1999-04-07 | 2000-11-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
US6663607B2 (en) | 1999-07-12 | 2003-12-16 | Scimed Life Systems, Inc. | Bioactive aneurysm closure device assembly and kit |
US6371980B1 (en) | 1999-08-30 | 2002-04-16 | Cardiovasc, Inc. | Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method |
US6409757B1 (en) * | 1999-09-15 | 2002-06-25 | Eva Corporation | Method and apparatus for supporting a graft assembly |
US6344052B1 (en) | 1999-09-27 | 2002-02-05 | World Medical Manufacturing Corporation | Tubular graft with monofilament fibers |
US6383171B1 (en) | 1999-10-12 | 2002-05-07 | Allan Will | Methods and devices for protecting a passageway in a body when advancing devices through the passageway |
IL140869A0 (en) | 2001-01-11 | 2002-02-10 | Mind Guard Ltd | Implantable expanding stroke preventing device and method of maufacturing |
IL140871A0 (en) | 2001-01-11 | 2002-02-10 | Mind Guard Ltd | Implantable composite stroke preventing device and method of manufacturing |
US20040010308A1 (en) * | 2000-01-18 | 2004-01-15 | Mindguard Ltd. | Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
US20040010307A1 (en) * | 2000-01-18 | 2004-01-15 | Mindguard Ltd. | Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
US6312463B1 (en) | 2000-02-01 | 2001-11-06 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
US20030114918A1 (en) | 2000-04-28 | 2003-06-19 | Garrison Michi E. | Stent graft assembly and method |
US6451050B1 (en) | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
US6520984B1 (en) | 2000-04-28 | 2003-02-18 | Cardiovasc, Inc. | Stent graft assembly and method |
US7153323B1 (en) | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
IL137326A0 (en) * | 2000-07-17 | 2001-07-24 | Mind Guard Ltd | Implantable braided stroke preventing device and method of manufacturing |
US6815184B2 (en) | 2000-07-31 | 2004-11-09 | Biolex, Inc. | Expression of biologically active polypeptide in duckweed |
CN1139480C (en) | 2000-08-14 | 2004-02-25 | 江宫商事股份有限公司 | Technology for manufacturing sole of heavy shoe |
US6579308B1 (en) | 2000-11-28 | 2003-06-17 | Scimed Life Systems, Inc. | Stent devices with detachable distal or proximal wires |
IL140870A0 (en) | 2001-01-11 | 2002-02-10 | Mind Guard Ltd | Deployment system for implantable self-expandable intraluminal devices |
US6488704B1 (en) * | 2001-05-07 | 2002-12-03 | Biomed Solutions, Llc | Implantable particle measuring apparatus |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
IL144213A0 (en) | 2001-07-09 | 2002-05-23 | Mind Guard Ltd | Implantable filter |
US6638294B1 (en) * | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
AU2002349792A1 (en) | 2001-11-23 | 2003-06-10 | Mindguard Ltd. | Implantable intraluminal protector device and method of using same for stabilizing atheromas |
AU2002347579A1 (en) | 2001-11-23 | 2003-06-10 | Mindguard Ltd. | Expandable delivery appliance particularly for delivering intravascular devices |
EP1467678A1 (en) | 2001-12-21 | 2004-10-20 | Cardiovasc, Inc. | Composite stent with polymeric covering and bioactive coating |
US7485122B2 (en) | 2002-06-27 | 2009-02-03 | Boston Scientific Scimed, Inc. | Integrated anchor coil in stretch-resistant vaso-occlusive coils |
WO2004050137A2 (en) | 2002-11-29 | 2004-06-17 | Mindguard Ltd. | Braided intraluminal device for stroke prevention |
US20040133129A1 (en) | 2003-01-03 | 2004-07-08 | Mindguard Ltd. | Measurements in a body lumen using guidewire with spaced markers |
US7951557B2 (en) | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
US7093527B2 (en) | 2003-06-10 | 2006-08-22 | Surpass Medical Ltd. | Method and apparatus for making intraluminal implants and construction particularly useful in such method and apparatus |
US20040267281A1 (en) | 2003-06-25 | 2004-12-30 | Eran Harari | Delivery system for self-expandable diverter |
WO2005044361A1 (en) | 2003-11-07 | 2005-05-19 | Merlin Md Pte Ltd | Implantable medical devices with enhanced visibility, mechanical properties and biocompatibility |
US7275471B2 (en) | 2003-12-29 | 2007-10-02 | Surpass Medical Ltd. | Mixed wire braided device with structural integrity |
US7069835B2 (en) | 2004-01-12 | 2006-07-04 | Surpass Medical Ltd. | Striped braided element |
SG133420A1 (en) | 2005-12-13 | 2007-07-30 | Merlin Md Pte Ltd | An endovascular device with membrane having permanently attached agents |
US8915952B2 (en) | 2004-03-31 | 2014-12-23 | Merlin Md Pte Ltd. | Method for treating aneurysms |
US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
EP1750619B1 (en) | 2004-05-25 | 2013-07-24 | Covidien LP | Flexible vascular occluding device |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
ES2306010T3 (en) | 2004-06-02 | 2008-11-01 | Millipore Corporation | DISPOSABLE BIREREACTOR. |
JP4680990B2 (en) | 2004-06-04 | 2011-05-11 | エクセラーエックス, インコーポレイテッド | Disposable bioreactor system and method |
US20070100321A1 (en) | 2004-12-22 | 2007-05-03 | Leon Rudakov | Medical device |
US20060190070A1 (en) | 2005-02-23 | 2006-08-24 | Dieck Martin S | Rail stent and methods of use |
US20060206198A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices and methods |
US20060206199A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
JP4945714B2 (en) | 2005-05-25 | 2012-06-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for supplying and deploying an occlusion device in a conduit |
CA2618776A1 (en) | 2005-08-10 | 2007-02-22 | Martin S. Dieck | Anti-restenotic therapeutic device |
US20070219619A1 (en) | 2005-10-27 | 2007-09-20 | Cardiovasc, Inc. | Partially covered stent devices and methods of use |
USD569976S1 (en) | 2005-12-22 | 2008-05-27 | Merlin Md Pte. Ltd. | Stent |
US20070185457A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Vascular occlusion delivery |
US20070185443A1 (en) | 2006-02-03 | 2007-08-09 | Starfire Medical, Inc. | Vascular therapy delivery system |
ES2375736T3 (en) | 2006-02-13 | 2012-03-05 | Merlin Md Pte Ltd | ENDOVASCULAR DEVICE WITH MEMBRANE. |
US20070239261A1 (en) | 2006-04-07 | 2007-10-11 | Arani Bose | Aneurysm occlusion system and method |
US20080114436A1 (en) | 2006-08-17 | 2008-05-15 | Dieck Martin S | Aneurysm covering devices and delivery devices |
JP2010500915A (en) | 2006-08-17 | 2010-01-14 | エヌフォーカス ニューロメディカル, インコーポレイテッド | Aneurysm isolation device |
US20080132743A1 (en) | 2006-12-01 | 2008-06-05 | Albemarle Corporation | Production of high purity decabromodiphenylalkanes |
US20090030400A1 (en) | 2007-07-25 | 2009-01-29 | Arani Bose | System and method for intracranial access |
US8956823B2 (en) | 2007-08-20 | 2015-02-17 | Bio-Rad Laboratories, Inc. | Anti-antibody reagent |
-
2002
- 2002-08-12 US US10/216,356 patent/US20030100945A1/en not_active Abandoned
- 2002-11-06 IL IL16208802A patent/IL162088A0/en unknown
- 2002-11-06 ES ES02785876T patent/ES2401426T3/en not_active Expired - Lifetime
- 2002-11-06 EP EP11185045.9A patent/EP2425800B8/en not_active Expired - Lifetime
- 2002-11-06 WO PCT/IL2002/000886 patent/WO2003043527A2/en not_active Application Discontinuation
- 2002-11-06 EP EP02785876A patent/EP1455679B1/en not_active Expired - Lifetime
- 2002-11-06 AU AU2002349793A patent/AU2002349793A1/en not_active Abandoned
- 2002-11-06 ES ES11185045T patent/ES2530873T3/en not_active Expired - Lifetime
-
2004
- 2004-08-04 US US10/910,621 patent/US7306624B2/en not_active Expired - Lifetime
-
2007
- 2007-10-16 US US11/907,675 patent/US7572290B2/en not_active Expired - Lifetime
-
2009
- 2009-07-02 US US12/496,672 patent/US7942925B2/en not_active Expired - Fee Related
-
2010
- 2010-02-21 US US12/709,483 patent/US8419787B2/en not_active Expired - Lifetime
Cited By (193)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050010281A1 (en) * | 2001-07-09 | 2005-01-13 | Ofer Yodfat | Implantable intraluminal device and method of using same in treating aneurysms |
US7942925B2 (en) | 2001-07-09 | 2011-05-17 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US7572290B2 (en) | 2001-07-09 | 2009-08-11 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US20080039933A1 (en) * | 2001-07-09 | 2008-02-14 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US7306624B2 (en) | 2001-07-09 | 2007-12-11 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US8419787B2 (en) | 2001-11-23 | 2013-04-16 | Surpass Medical Ltd | Implantable intraluminal device and method of using same in treating aneurysms |
US20100198334A1 (en) * | 2001-11-23 | 2010-08-05 | Surpass Medical Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US20080038232A1 (en) * | 2003-04-27 | 2008-02-14 | Protalix Ltd. | Production of high mannose proteins in plant culture |
US7951557B2 (en) | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
US20100196345A1 (en) * | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
US20090208477A1 (en) * | 2003-04-27 | 2009-08-20 | Protalix Ltd. | Production of high mannose proteins in plant culture |
US8790641B2 (en) | 2003-04-27 | 2014-07-29 | Protalix Ltd. | Production of high mannose proteins in plant culture and therapeutic uses thereof |
US8876886B2 (en) | 2003-07-30 | 2014-11-04 | Jotec Gmbh | Braided stent to be implanted in a blood vessel |
US20090216307A1 (en) * | 2003-07-30 | 2009-08-27 | Jotec Gmbh | Braided stent to be implanted in a blood vessel |
US20060184238A1 (en) * | 2003-07-30 | 2006-08-17 | Ralf Kaufmann | Braided stent to be implanted in a blood vessel |
US7582108B2 (en) * | 2003-10-28 | 2009-09-01 | Deutsche Institute für Textil-und Faserforschung Stuttgart Stiftung des Oeffentlichen Rechts | Tubular implant |
US20050143805A1 (en) * | 2003-10-28 | 2005-06-30 | Helmut Hierlemann | Tubular implant |
US20070100430A1 (en) * | 2004-03-30 | 2007-05-03 | Leon Rudakov | Medical device |
US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
EP1732467A1 (en) * | 2004-03-31 | 2006-12-20 | Merlin MD PTE Ltd | A medical device |
US11033378B2 (en) | 2004-03-31 | 2021-06-15 | Merlin Md Pte Ltd. | Medical device |
US9844433B2 (en) | 2004-03-31 | 2017-12-19 | Merlin Md Pte. Ltd. | Medical device |
US10390934B2 (en) | 2004-03-31 | 2019-08-27 | Merlin Md Pte. Ltd. | Medical device |
US9585668B2 (en) | 2004-03-31 | 2017-03-07 | Merlin Md Pte Ltd | Medical device |
US9433518B2 (en) | 2004-03-31 | 2016-09-06 | Merlin Md Pte. Ltd. | Medical device |
US20070255388A1 (en) * | 2004-03-31 | 2007-11-01 | Merlin Md Pte Ltd | Endovascular device with membrane |
EP1732467A4 (en) * | 2004-03-31 | 2010-09-15 | Merlin Md Pte Ltd | A medical device |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
US8920430B2 (en) | 2004-03-31 | 2014-12-30 | Merlin Md Pte. Ltd. | Medical device |
US20070100426A1 (en) * | 2004-03-31 | 2007-05-03 | Leon Rudakov | Medical device |
US9855047B2 (en) | 2004-05-25 | 2018-01-02 | Covidien Lp | Flexible vascular occluding device |
US9295568B2 (en) | 2004-05-25 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US9161851B2 (en) * | 2004-05-25 | 2015-10-20 | Covidien Lp | Vascular stenting for aneurysms |
US9801744B2 (en) | 2004-05-25 | 2017-10-31 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140172071A1 (en) * | 2004-05-25 | 2014-06-19 | Covidien Lp | Vascular stenting for aneurysms |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US8382825B2 (en) | 2004-05-25 | 2013-02-26 | Covidien Lp | Flexible vascular occluding device |
US10765542B2 (en) | 2004-05-25 | 2020-09-08 | Covidien Lp | Methods and apparatus for luminal stenting |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US8398701B2 (en) * | 2004-05-25 | 2013-03-19 | Covidien Lp | Flexible vascular occluding device |
US10918389B2 (en) | 2004-05-25 | 2021-02-16 | Covidien Lp | Flexible vascular occluding device |
US20050267568A1 (en) * | 2004-05-25 | 2005-12-01 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US11771433B2 (en) | 2004-05-25 | 2023-10-03 | Covidien Lp | Flexible vascular occluding device |
US8617234B2 (en) * | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
EP2419048A4 (en) * | 2004-05-25 | 2014-04-09 | Covidien Lp | Vascular stenting for aneurysms |
US20060206199A1 (en) * | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
US20060206198A1 (en) * | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices and methods |
US10070977B2 (en) | 2005-05-24 | 2018-09-11 | Inspire M.D. Ltd | Stent apparatuses for treatment via body lumens and methods of use |
US10932926B2 (en) | 2005-05-24 | 2021-03-02 | Inspiremd Ltd. | Stent assembly and methods for treatment via body lumens |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
US10058440B2 (en) | 2005-05-24 | 2018-08-28 | Inspiremd, Ltd. | Carotid stent apparatus and methods for treatment via body lumens |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8257421B2 (en) | 2005-05-25 | 2012-09-04 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US20090318947A1 (en) * | 2005-05-25 | 2009-12-24 | Chestnut Medical Technologies, Inc. | System and method for delivering and deploying an occluding device within a vessel |
US10064747B2 (en) | 2005-05-25 | 2018-09-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9381104B2 (en) | 2005-05-25 | 2016-07-05 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US20090192536A1 (en) * | 2005-05-25 | 2009-07-30 | Chestnut Medical Technologies, Inc. | System and method for delivering and deploying an occluding device within a vessel |
US8236042B2 (en) | 2005-05-25 | 2012-08-07 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8147534B2 (en) | 2005-05-25 | 2012-04-03 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US10322018B2 (en) | 2005-05-25 | 2019-06-18 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US20070060994A1 (en) * | 2005-09-12 | 2007-03-15 | Gobran Riad H | Blood flow diverters for the treatment of intracranial aneurysms |
US20090054966A1 (en) * | 2006-02-13 | 2009-02-26 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US9610181B2 (en) | 2006-02-22 | 2017-04-04 | Covidien Lp | Stents having radiopaque mesh |
US11382777B2 (en) | 2006-02-22 | 2022-07-12 | Covidien Lp | Stents having radiopaque mesh |
US8394119B2 (en) | 2006-02-22 | 2013-03-12 | Covidien Lp | Stents having radiopaque mesh |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US10433988B2 (en) | 2006-02-22 | 2019-10-08 | Covidien Lp | Stents having radiopaque mesh |
US20080033341A1 (en) * | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
US20100324651A1 (en) * | 2006-10-18 | 2010-12-23 | Asher Holzer | Knitted Stent Jackets |
US20100324664A1 (en) * | 2006-10-18 | 2010-12-23 | Asher Holzer | Bifurcated Stent Assemblies |
US10137015B2 (en) | 2006-10-18 | 2018-11-27 | Inspiremd Ltd. | Knitted stent jackets |
US9132261B2 (en) | 2006-10-18 | 2015-09-15 | Inspiremd, Ltd. | In vivo filter assembly |
US20100241214A1 (en) * | 2006-11-22 | 2010-09-23 | Inspiremd Ltd. | Optimized stent jacket |
US10406008B2 (en) | 2006-11-22 | 2019-09-10 | Inspiremd, Ltd. | Optimized stent jacket having single fiber mesh |
US10406006B2 (en) | 2006-11-22 | 2019-09-10 | Inspiremd, Ltd. | Methods of providing optimized drug-eluting stent assemblies |
US9526644B2 (en) | 2006-11-22 | 2016-12-27 | Inspiremd, Ltd. | Optimized drug-eluting stent assembly methods |
EP2088962A2 (en) * | 2006-11-22 | 2009-08-19 | Inspiremd Ltd. | Optimized stent jacket |
US9132003B2 (en) | 2006-11-22 | 2015-09-15 | Inspiremd, Ltd. | Optimized drug-eluting stent assembly |
EP2088962A4 (en) * | 2006-11-22 | 2013-03-13 | Inspiremd Ltd | Optimized stent jacket |
US11051959B2 (en) | 2006-11-22 | 2021-07-06 | Inspiremd, Ltd. | Intravascular aneurysm treatment device and methods |
US10070976B2 (en) * | 2006-11-22 | 2018-09-11 | Inspiremd Ltd. | Optimized stent jacket |
US9782281B2 (en) | 2006-11-22 | 2017-10-10 | Inspiremd, Ltd. | Stent-mesh assembly and methods |
US20100112700A1 (en) * | 2007-05-07 | 2010-05-06 | Protalix Ltd. | Large scale disposable bioreactor |
US10364413B2 (en) | 2007-05-07 | 2019-07-30 | Protalix Ltd. | Large scale disposable bioreactor |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US10610389B2 (en) | 2008-05-13 | 2020-04-07 | Covidien Lp | Braid implant delivery systems |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US9833309B2 (en) | 2009-03-06 | 2017-12-05 | The Regents Of The University Of California | Thin film vascular stent and biocompatible surface treatment |
CN105055061A (en) * | 2009-04-17 | 2015-11-18 | 泰科保健集团有限合伙公司 | Vascular stenting for aneurysms |
US8636760B2 (en) | 2009-04-20 | 2014-01-28 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10548748B2 (en) | 2009-06-23 | 2020-02-04 | Covidien Lp | Procedures for vascular occlusion |
US9867723B2 (en) | 2009-06-23 | 2018-01-16 | Covidien Lp | Procedures for vascular occlusion |
US11564817B2 (en) | 2009-06-23 | 2023-01-31 | Covidien Lp | Procedures for vascular occlusion |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US10383748B2 (en) | 2009-12-21 | 2019-08-20 | Covidien Lp | Procedures for vascular occlusion |
US9668891B2 (en) | 2009-12-21 | 2017-06-06 | Covidien Lp | Procedures for vascular occlusion |
US9408728B2 (en) | 2009-12-21 | 2016-08-09 | Covidien Lp | Procedures for vascular occlusion |
US9730783B2 (en) | 2010-05-25 | 2017-08-15 | The Regents Of The University Of California | Ultra-low fractional area coverage flow diverter for treating aneurysms and vascular diseases |
US20140114343A1 (en) * | 2011-05-26 | 2014-04-24 | The Asan Foundation | Stent for the coil embolization of a cerebral aneurysm |
US9849007B2 (en) * | 2012-02-13 | 2017-12-26 | Board Of Regents Of The University Of Texas System | Scaffold system for tissue repair |
US20130218253A1 (en) * | 2012-02-13 | 2013-08-22 | J. Jordan Massey Kaufmann | Scaffold system for tissue repair |
US9259334B2 (en) * | 2012-02-13 | 2016-02-16 | Board Of Regents Of The University Of Texas System | Scaffold system for tissue repair |
US20160287415A1 (en) * | 2012-02-13 | 2016-10-06 | The Board Of Regents Of The University Of Texas System | Scaffold system for tissue repair |
US10987208B2 (en) | 2012-04-06 | 2021-04-27 | Merlin Md Pte Ltd. | Devices and methods for treating an aneurysm |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9877856B2 (en) | 2012-07-18 | 2018-01-30 | Covidien Lp | Methods and apparatus for luminal stenting |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US9907643B2 (en) | 2012-10-30 | 2018-03-06 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US10952878B2 (en) | 2012-10-31 | 2021-03-23 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US10206798B2 (en) | 2012-10-31 | 2019-02-19 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9561122B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9655999B2 (en) | 2013-03-12 | 2017-05-23 | Carnegie Mellon University | Coated vaso-occlusive device for treatment of aneurysms |
US10034966B2 (en) | 2013-03-12 | 2018-07-31 | Carnegie Mellon University | Coated vaso-occlusive device and methods for treatment of aneurysms |
US11298144B2 (en) | 2013-03-15 | 2022-04-12 | Insera Therapeutics, Inc. | Thrombus aspiration facilitation systems |
US10342655B2 (en) | 2013-03-15 | 2019-07-09 | Insera Therapeutics, Inc. | Methods of treating a thrombus in an artery using cyclical aspiration patterns |
US9592068B2 (en) | 2013-03-15 | 2017-03-14 | Insera Therapeutics, Inc. | Free end vascular treatment systems |
US8721676B1 (en) | 2013-03-15 | 2014-05-13 | Insera Therapeutics, Inc. | Slotted vascular treatment devices |
US8733618B1 (en) | 2013-03-15 | 2014-05-27 | Insera Therapeutics, Inc. | Methods of coupling parts of vascular treatment systems |
US8882797B2 (en) | 2013-03-15 | 2014-11-11 | Insera Therapeutics, Inc. | Methods of embolic filtering |
US9833251B2 (en) | 2013-03-15 | 2017-12-05 | Insera Therapeutics, Inc. | Variably bulbous vascular treatment devices |
US10463468B2 (en) | 2013-03-15 | 2019-11-05 | Insera Therapeutics, Inc. | Thrombus aspiration with different intensity levels |
US8753371B1 (en) | 2013-03-15 | 2014-06-17 | Insera Therapeutics, Inc. | Woven vascular treatment systems |
US8895891B2 (en) | 2013-03-15 | 2014-11-25 | Insera Therapeutics, Inc. | Methods of cutting tubular devices |
US10251739B2 (en) | 2013-03-15 | 2019-04-09 | Insera Therapeutics, Inc. | Thrombus aspiration using an operator-selectable suction pattern |
US9750524B2 (en) | 2013-03-15 | 2017-09-05 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy systems |
US8910555B2 (en) | 2013-03-15 | 2014-12-16 | Insera Therapeutics, Inc. | Non-cylindrical mandrels |
US9901435B2 (en) | 2013-03-15 | 2018-02-27 | Insera Therapeutics, Inc. | Longitudinally variable vascular treatment devices |
US8904914B2 (en) | 2013-03-15 | 2014-12-09 | Insera Therapeutics, Inc. | Methods of using non-cylindrical mandrels |
US8783151B1 (en) | 2013-03-15 | 2014-07-22 | Insera Therapeutics, Inc. | Methods of manufacturing vascular treatment devices |
US9314324B2 (en) | 2013-03-15 | 2016-04-19 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US8852227B1 (en) | 2013-03-15 | 2014-10-07 | Insera Therapeutics, Inc. | Woven radiopaque patterns |
US9179995B2 (en) | 2013-03-15 | 2015-11-10 | Insera Therapeutics, Inc. | Methods of manufacturing slotted vascular treatment devices |
US8789452B1 (en) | 2013-03-15 | 2014-07-29 | Insera Therapeutics, Inc. | Methods of manufacturing woven vascular treatment devices |
US8721677B1 (en) | 2013-03-15 | 2014-05-13 | Insera Therapeutics, Inc. | Variably-shaped vascular devices |
US9179931B2 (en) | 2013-03-15 | 2015-11-10 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy systems |
US10335260B2 (en) | 2013-03-15 | 2019-07-02 | Insera Therapeutics, Inc. | Methods of treating a thrombus in a vein using cyclical aspiration patterns |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US9649187B2 (en) | 2013-05-14 | 2017-05-16 | Cook Medical Technologies Llc | Implantable flow diverter |
JP2016527002A (en) * | 2013-07-17 | 2016-09-08 | レイク リージョン マニュファクチュアリング インコーポレイテッド | Device for embolism protection in large flow area |
US8728117B1 (en) | 2013-07-29 | 2014-05-20 | Insera Therapeutics, Inc. | Flow disrupting devices |
US8866049B1 (en) | 2013-07-29 | 2014-10-21 | Insera Therapeutics, Inc. | Methods of selectively heat treating tubular devices |
US8795330B1 (en) | 2013-07-29 | 2014-08-05 | Insera Therapeutics, Inc. | Fistula flow disruptors |
US8828045B1 (en) | 2013-07-29 | 2014-09-09 | Insera Therapeutics, Inc. | Balloon catheters |
US8845679B1 (en) | 2013-07-29 | 2014-09-30 | Insera Therapeutics, Inc. | Variable porosity flow diverting devices |
US8845678B1 (en) | 2013-07-29 | 2014-09-30 | Insera Therapeutics Inc. | Two-way shape memory vascular treatment methods |
US8715317B1 (en) | 2013-07-29 | 2014-05-06 | Insera Therapeutics, Inc. | Flow diverting devices |
US10751159B2 (en) | 2013-07-29 | 2020-08-25 | Insera Therapeutics, Inc. | Systems for aspirating thrombus during neurosurgical procedures |
US8932321B1 (en) | 2013-07-29 | 2015-01-13 | Insera Therapeutics, Inc. | Aspiration systems |
US8790365B1 (en) | 2013-07-29 | 2014-07-29 | Insera Therapeutics, Inc. | Fistula flow disruptor methods |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US8859934B1 (en) | 2013-07-29 | 2014-10-14 | Insera Therapeutics, Inc. | Methods for slag removal |
US8784446B1 (en) | 2013-07-29 | 2014-07-22 | Insera Therapeutics, Inc. | Circumferentially offset variable porosity devices |
US8803030B1 (en) | 2013-07-29 | 2014-08-12 | Insera Therapeutics, Inc. | Devices for slag removal |
US8932320B1 (en) | 2013-07-29 | 2015-01-13 | Insera Therapeutics, Inc. | Methods of aspirating thrombi |
US8816247B1 (en) | 2013-07-29 | 2014-08-26 | Insera Therapeutics, Inc. | Methods for modifying hypotubes |
US8735777B1 (en) | 2013-07-29 | 2014-05-27 | Insera Therapeutics, Inc. | Heat treatment systems |
US8870910B1 (en) | 2013-07-29 | 2014-10-28 | Insera Therapeutics, Inc. | Methods of decoupling joints |
US8715316B1 (en) | 2013-07-29 | 2014-05-06 | Insera Therapeutics, Inc. | Offset vascular treatment devices |
US8813625B1 (en) | 2013-07-29 | 2014-08-26 | Insera Therapeutics, Inc. | Methods of manufacturing variable porosity flow diverting devices |
US8863631B1 (en) | 2013-07-29 | 2014-10-21 | Insera Therapeutics, Inc. | Methods of manufacturing flow diverting devices |
US8728116B1 (en) | 2013-07-29 | 2014-05-20 | Insera Therapeutics, Inc. | Slotted catheters |
US8870901B1 (en) | 2013-07-29 | 2014-10-28 | Insera Therapeutics, Inc. | Two-way shape memory vascular treatment systems |
US8872068B1 (en) | 2013-07-29 | 2014-10-28 | Insera Therapeutics, Inc. | Devices for modifying hypotubes |
US8869670B1 (en) | 2013-07-29 | 2014-10-28 | Insera Therapeutics, Inc. | Methods of manufacturing variable porosity devices |
EP2837361A1 (en) | 2013-08-13 | 2015-02-18 | Cook Medical Technologies LLC | Implantable flow adjuster |
US9844452B2 (en) | 2013-08-13 | 2017-12-19 | Cook Medical Technologies Llc | Implantable flow adjuster |
US20170265869A1 (en) * | 2014-08-07 | 2017-09-21 | Perflow Medical Ltd. | Aneurysm treatment device and method |
US10792043B2 (en) * | 2014-08-07 | 2020-10-06 | Perflow Medical Ltd. | Aneurysm treatment device and method |
US11771436B2 (en) | 2014-08-07 | 2023-10-03 | Perflow Medical Ltd. | Aneurysm treatment device and method |
US11547415B2 (en) * | 2016-07-22 | 2023-01-10 | Route 92 Medical, Inc. | Endovascular interventions in neurovascular anatomy |
US20210338251A1 (en) * | 2018-02-08 | 2021-11-04 | Covidien Lp | Vascular expandable devices |
US20210338462A1 (en) * | 2018-02-08 | 2021-11-04 | Covidien Lp | Vascular expandable devices |
US11065009B2 (en) * | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
US11065136B2 (en) * | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
US11759342B2 (en) * | 2018-02-08 | 2023-09-19 | Covidien Lp | Vascular expandable devices |
CN110123502A (en) * | 2018-02-08 | 2019-08-16 | 柯惠有限合伙公司 | Blood vessel distensible devices |
US20190239895A1 (en) * | 2018-02-08 | 2019-08-08 | Covidien Lp | Vascular expandable devices |
CN108210134A (en) * | 2018-02-27 | 2018-06-29 | 北京航空航天大学 | A kind of intravascular stent |
Also Published As
Publication number | Publication date |
---|---|
US20090270970A1 (en) | 2009-10-29 |
US20050010281A1 (en) | 2005-01-13 |
EP2425800B1 (en) | 2014-12-17 |
US7572290B2 (en) | 2009-08-11 |
AU2002349793A8 (en) | 2003-06-10 |
EP2425800B8 (en) | 2015-01-28 |
EP2425800A2 (en) | 2012-03-07 |
US8419787B2 (en) | 2013-04-16 |
US7306624B2 (en) | 2007-12-11 |
EP1455679A2 (en) | 2004-09-15 |
EP2425800A3 (en) | 2012-09-19 |
WO2003043527A2 (en) | 2003-05-30 |
IL162088A0 (en) | 2005-11-20 |
US20080039933A1 (en) | 2008-02-14 |
EP1455679B1 (en) | 2013-01-02 |
ES2401426T3 (en) | 2013-04-19 |
US20100198334A1 (en) | 2010-08-05 |
WO2003043527A3 (en) | 2004-03-18 |
AU2002349793A1 (en) | 2003-06-10 |
EP1455679A4 (en) | 2009-07-22 |
US7942925B2 (en) | 2011-05-17 |
ES2530873T3 (en) | 2015-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1455679B1 (en) | Implantable intraluminal device and method of using same in treating aneurysms | |
EP1750619B1 (en) | Flexible vascular occluding device | |
US9539122B2 (en) | Aneurysm treatment device and method of use | |
US20230149022A1 (en) | Filamentary devices for treatment of vascular defects | |
CA2335333C (en) | Self expanding bifurcated endovascular prosthesis | |
US7811314B2 (en) | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation | |
US20110054589A1 (en) | Stent with variable cross section braiding filament and method for making same | |
US20040122468A1 (en) | Braided intraluminal device for stroke prevention | |
EP0864302A2 (en) | Articulated expandable intraluminal stent | |
US20030100940A1 (en) | Implantable intraluminal protector device and method of using same for stabilizing atheromas | |
JPH10328216A (en) | Stent for treating bifurcate vessel and stent graft | |
AU2011213729B2 (en) | Flexible vascular occluding device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MINDGUARD LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YODFAT, OFER;LIEBER, BARUCH;GRAD, YGAEL;AND OTHERS;REEL/FRAME:013204/0886 Effective date: 20020729 |
|
AS | Assignment |
Owner name: SURPASS MEDICAL LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MINDGUARD LTD. (IN VOLUNTARY LIQUIDATION);REEL/FRAME:017121/0479 Effective date: 20060117 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: SURPASS MEDICAL LTD., ISRAEL Free format text: CONFIRMATORY ASSIGNMENT;ASSIGNORS:YODFAT, OFER;LIEBER, BARUCH;GRAD, YGAEL;AND OTHERS;REEL/FRAME:023564/0525;SIGNING DATES FROM 20091029 TO 20091102 Owner name: SURPASS MEDICAL LTD., ISRAEL Free format text: CONFIRMATORY ASSIGNMENT;ASSIGNORS:YODFAT, OFER;LIEBER, BARUCH;GRAD, YGAEL;AND OTHERS;SIGNING DATES FROM 20091029 TO 20091102;REEL/FRAME:023564/0525 |
|
AS | Assignment |
Owner name: STRYKER CORPORATION, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SURPASS MEDICAL LTD;REEL/FRAME:032223/0302 Effective date: 20140207 |